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In Escherichia coli, the RNA degradosome is a protein complex involved in the general 
degradation of mRNA and in post-transcriptional gene regulation. The principal 
components of the degradosome complex are the endoribonuclease RNase E, the 
phosphorolytic exoribonuclease PNPase, the ATP-dependent RNA helicase RhlB, and 
the glycolytic enzyme enolase. The RNase E protein is a 1061 amino acid protein which 
can be divided into three major functional portions: the N-terminal catalytic activity 
portion; the central membrane anchoring and RNA binding portion; and the C terminal 
protein-interaction portion which bind to other major degradosome components. 
RraA and RraB (Regulator of RNase E activity) are protein regulators of RNase E 
discovered in our lab, which regulate RNase E by binding to the RNase E C-terminal 
region. The work presented here describes the regulation of rraB gene expression and in 
vitro studies of degradosome assembly and the effects of RraA/RraB inhibition. 
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rraB is transcribed from its own promoter PrraB. A transposon insertion into glmS 
encoding glucosamine-6P synthase resulted in a 4 fold increase in the PrraB activity from 
a PrraB-lacZ fusion the indicating that glmS is serves as a negative regulator of rraB 
transcription. Consistent with this discovery, real-time RT-PCR revealed that glmS::Tn5 
results in a 5-fold increase on the steady-state level of rraB mRNA. 
As part of this work we have reconstituted the degradosome from individually purified 
proteins. The binding sites of RraA and RraB overlap with the RNA binding and the 
RhlB interaction sites within the C-terminus of RNase E. We have characterized the 
effects of RraA and RraB on the decay of various RNA substrates by reconstituted 
degradosomes: RraA and RraB proteins were shown to inhibit the hydrolysis reaction a 
short substrate by RNase E by up to 50% in a mixed inhibition pattern. Inhibition of the 
decay of the long RNA substrates RNA1 or dsbC was much more severe with the RNA 
processing activity becoming reduced by as much as 80%. These studies have delineated 
the kinetic consequences of inhibition by RraA and RraB and provide further insights 
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CHAPTER 1 RESEARCH BACKGROUND 
Overview 
The cleavage of RNA by ribonucleases is a fundamental process for cell survival and for 
adaptation to different environments. RNase E is an essential endonuclease that plays a 
key role in RNA turnover and is conserved amongst proteobacteria. RNase E homologues 
have also been identified in Achaea and plants. RNase E is the central component of a 
multi-enzyme complex known as the RNA degradosome, which is involved in both the 
general degradation of mRNA and in posttranscriptional gene regulation.  
The degradosome is a 500-700KDa complex formed by the assembly of the enzymes 
polynucleotide phosphorylase (PNPase), the DEAD-box family helicase RhlB, and the 
glycolytic enzyme enolase onto the C-terminal half of the RNase E protein. Besides those 
major components, other proteins are found associated with the degradosome under 
certain conditions, such as the chaperone DnaK and the DEAD helicase RhlE and CdsA. 
Whether degradosome formation is required in mRNA decay in vivo has been 
controversial. It is known that the majority of enolase and Pnpase are unattached to 
RNase E in vivo. Furthermore, RhlB and Pnpase can form a protein complex independent 
of RNase E.(Bernstein, Lin, Cohen, & Lin-Chao, 2004) While the overall significance of 
the degradosome has been established, how the individual component enzyme cooperate 
in carrying out RNA degradation or how changes in the degradosome composition affect 
the decay of different transcripts are still not clear. (Carpousis, Luisi, & McDowall, 2009) 
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RNase E protein structure and function 
The E.coli RNase E protein which is encoded by rne gene, comprises 1061 residues and 
can be divided into three major functional portions: The N terminal portion contains the 
endoribonuclease activity domain and a zinc finger region; the central portion includes 
membrane anchoring segment A and its flanking regions, followed by Arginine rich RNA 
binding domain (ARRBD); the C terminal portion is a natively unstructured protein 
segment which binds to other major degradosome components. Structural and functional 
analysis of the N terminal portion and the co-crystallized of the C terminal fragments to 
its binding proteins have converged to the advanced understanding in function and 
regulation of RNA degradosome.   
THE N TERMINAL HALF OF RNASE E 
The N terminal (1 to 529 amino acids) of the RNase E catalytic core contains a large 
domain (1-400) which contains the substrate binding and the catalytic sites, a Zn-link 
region(401-411) which binds to Zinc ions and a small domain (415-529) which is 
involved in sub-domain organization. The crystal structure revealed that the RNase E 
holo enzyme comprises of four N terminal domain monomers (the rest of the protein is 
unstructured and hence cannot be detected by X-ray crystallography). 
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Figure 1.1 Crystal structure of N-terminal Catalytic Half of RNase E (Adapted from 
Callaghan et al., 2005a) 
 
The large domain starts with two RNase H-like domains within which embedded a S1 
RNA binding domain followed by a 5′ sensor region (Callaghan et al.2005b).  RNase H 
is a non-specific endonuclease which cleaves the 3´-O-P bond of RNA in a DNA/RNA 
duplex, producing 3´-hydroxyl and 5´-phosphate terminated products. The RNase H like 
domains in RNase E functions structurally, i.e.it presents RNA substrate to the activity 
site, but there is no RNase H activity involved. Two of the well studied rne temperature 
sensitive mutants, rne-1 (Gly 66 to Ser) and rne-3071(Leu 68 to Phe) which cannot grow 
at elevated temperatures presumably due to its inability to process rRNA and tRNAs have 
been mapped to the S1 RNA binding domain. Because RNA substrate binding involves 
both the S1 domain and the 5′ sensor, compensatory amino acids substitutions have been 
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found in the 5′ sensor region to suppress these temperature sensitive mutants. For 
example, rne-187 (Arg187 to Leu) can suppress both rne-1 and rne-3071. In these double 
mutants (rne187/rne-1 and rne187/rne3071), the 5S rRNA processing and tRNA 
maturation is restored, however mRNA decay remains defective. This indicates that 
RNase E may utilize different strategies towards different RNA substrates (Perwez et al., 
2008). In addition to RNA binding, the S1 domain also participates in the dimerization of 
RNase E catalytic core. Another dimer interaction is located within the conserved Cys 
motif which forms a zinc link between two protomers. These two interactions are referred 
as the isologous interface in the tetramer. (Callaghan et al., 2003) 
RNase E has been demonstrated to prefer  5′ mono-phosphate RNA substrates, with 20-
30 fold higher in vitro activity towards mono-phosphate RNAs  than tri-phosphate RNAs 
when using 9S RNA or rpsT mRNA as substrates (Mackie, 1998). Recent work showed 
that 5′ mono-phosphate requirement for RNase E catalysis is dispensable in vivo. A 
mutation located in the 5′ sensor (R171Q), which shows disrupted RNA binding and 
significant reduced activity in vitro, is still viable albeit its slower growth rate and 
reduced tRNA processing ability in some cases (Garrey et al., 2009) Moreover, in 
contrast to previously studied tri-phosphate 9S RNA and tri-phosphate RNA1 which are 
stable because of their 5′ tri-phosphate protection, the tri-phosphate cspA mRNA, can be 
rapidly degraded by RNase E NTH regardless of its 5′ phosphate status. Notably the 
cleavage of 9S RNA and RNA1 by RNase E are different from that of the cspA mRNA. 
9S RNA and RNA1 both contain an extended A/U rich 5′ single stranded region, where 
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RNase E has “direct” entry. However, the cleavage site of the cspA mRNA is relatively 
downstream, it is a short single stranded region bracketed by two step loop structures, 
significantly distant from the 5′ end, therefore requires “internal entry” of RNase E. 
(Kime, Jourdan, Stead, Hidalgo-Sastre, & McDowall, 2009). Although this phenomenon  
seems to be complex, the current understanding is that  “direct” entry, compared to 
internal entry of RNase E, relies more on 5′ phosphate status (Jourdan, Kime, & 
McDowall, 2010). Therefore, RNase E substrate specificity involves more than just the 5′ 
sensor region, especially with long, structured RNA substrates. Other regions involved in 
substrate binding will be discussed in detail below. 
The second half of the large domain is DNase I region that contains the active site. Based 
on the solved crystal structure of RNase E N terminal catalytic half protein (trapped with 
a 13mer allosteric RNA substrate), amino acids located in DNase I region, namely, 
Asp303, Asp346 and Asn305 are predicted to be the active site residues. These residues 
are in cooperation with a magnesium ion which is hydrated and is in proximity to RNA 
phosphate backbone (Callaghan et al., 2005b). In another effort to identify key amino 
acids in the catalytic domain of RNase E essential for function, several mutations within 
the DNase I domain that cause defects in RNA substrate binding but remain catalytically 
active have been identified (e.g. A326T and L385P) suggesting an additional role of 
DNase I region in RNA binding, especially for highly structured, natural RNase E 
substrates (Shin et al., 2008). 
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Between the large and small domains of N-terminal RNase E, there is a zinc link region 
(401-411aa). This region is conserved in the RNase E protein family among species, with 
each protomer contributing two cysteine thiols towards chelating the metal ion, i.e. two 
protomers share one zinc ion. Formation of the tetramer, or more precisely, dimer of 
dimers, requires both S1 domain dimerization (Schubert et al., 2004), Zn-link interactions 
(forming the isologous interface) and a domain-domain interaction between the small 
domains (heterologous interface). The heterologous interface between small domains is 
independent of the zinc-link and more flexible compared to the isologous interface. This 
flexibility is reflected in the “induced fit” during substrate binding. Upon binding to RNA 
substrate, the heterologous interface bends 60 degrees to bring RNase E to a relatively 
closed conformation (Koslover et al., 2008a).   
THE C TERMINAL HALF OF RNASE E 
The C terminal half of RNase E is less conserved and is unstructured. It consists of 4 
segments of increased structural propensity (RISP), designated as segments A, B, C, and 
D. These segments interact with other cellular components, namely, the cytoplamic 










Figure 1.2 Schematic map of RNase E C terminal scaffolding domain. (Adapted from 
Gorna et al., 2010) 
 
Previously, RNase E is known to form a cytoskeleton-like structure attached to cell 
membrane. It has been suspected that this organization is related to its interaction with 
cytoskeletal protein, namely the unique bacterial cytoskeletal protein MinD. Although 
RNase E is found to interact with MinD in a yeast two hybrid analysis, the cytoskeleton-
like organization of RNase E is independent of MinD, or the other known cytoskeletal 
structure protein MreB which is the actin-homolog in bacteria (Taghbalout & Rothfield, 
2007). This mystery was solved later by in vitro analysis: the membrane-anchoring 
domain of RNase E has been defined, which is Segment A (568-582aa). Segment A 
forms an amphipathic  helix that can bind to lipid vesicles with the dissociation constants 
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at approximately 1µM. In agreement with this observation, the RNase E full length 
protein is also able to bind phosphor-lipid vesicles. In addition, interaction with 
phosphor-lipid vesicle does not affect the endoribonuclease activity of RNase E 
(Khemici, Poljak, Luisi, & Carpousis, 2008). However, RNase E mutant with deletions of 
segment A has a slower growth rate and smaller colony size compared to wild type. It is 
likely that cytoskeleton-like organization of RNase E plays important role in its cellular 
function. One promising hypothesis is that membrane-anchoring is a storage mode of 
RNase E which limits its cytoplasmic availability. This is in agreement of the excess 
amount of RNase E protein detected in vivo as discussed in RNase E transcription 
regulation part below. In this notion, the loss of membrane-anchoring could result in 
elevated RNase E activity which is toxic to normal growth. 
As mentioned above, previous studies focused on the catalytic core of RNase E implied 
the existence of alternative RNA substrate binding sites. In the central region of RNase E, 
following the segment A, there is an Arginine Rich RNA Binding Domain (ARRBD, 
604-688aa), which contains the first coiled coil structure (633-652aa) and partially 
overlaps with Segment B (633-712aa). Segment B contains two coiled coil structures, 
633-652aa and 685-712aa. The Arginine Rich domain, along with the two coiled coil 
structures E have been shown to mediate the binding of substrate RNAs, even without the 
N terminal catalytic core of RNase E (Taraseviciene, Laimute, Bjork, Glenn R. And 
Uhlin, 1995). Segment B also overlaps with the RhlB interaction site. The region of 
RNase E which interacts with RhlB was first referred to as the R region (628-843aa), 
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(Callaghan et al., 2004) and then refined to a smaller fraction within the R region (698-
762aa) (Chandran et al., 2007a). Both of these fragments can stimulate the ATP 
dependent RNA unwinding activity of RhlB, with 628-843 fragments being comparably 
more efficient than the 698-762 fragments. It is quite common in DEAD box helicases 
that RNA binding is enhanced upon binding of the helicase to other proteins. In the case 
of RhlB, the RNA binding affinity which is mainly located in the C terminal region of 
protein is enhanced cooperatively in the presence of RNase E 628-843aa fragment. 
Indeed, the 628-843aa fragments contain a second RNA binding region (AR2), which is 
also Arginine rich (798-819aa). Both RNA binding domains in the central region (628-
843aa) could contribute to the enhanced binding of substrate in RNase E (628-
843aa)/RhlB complex compared to RhlB alone (Chandran et al., 2007a). The cooperation 
between RhlB and RNase E is substrate specific. It is possible that such cooperative 
action is only required for highly structured complex RNA substrate, such as RNA1, yet 
not necessary for RNA substrates that can be processed by cellular nucleases other than 
RNase E (Nishio & Itoh, 2009). 
Segment C (839-850aa) of the RNase E C terminal scaffold domain is conserved among a 
subgroup of -bacteria and serves as the binding site for enolase. The RNase E CTD-
enolase complex does not bind to Pnpase, because it excludes the segment D, which 
binds to Pnpase. It is noteworthy that the native RNase E CTD-enolase complex does not 
bind to RhlB even through it contains an RhlB binding site (Callaghan et al., 2004) 
Binding of RNase E fragments does not change enolase activity. Moreover, only one 
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tenth of the enolase inside the cell is sequestered into the degradosome complex.  In fact 
the function of enolase in degradosome is still unclear. One interesting hypothesis is that 
enolase relates cellular energy level to post-transcriptional gene regulations (Callaghan et 
al., 2004). 
The aforementioned Segment D (1021-1061aa) of RNase E binds to the periphery region 
of Pnpase in a pseudo-continuous anti-parallel beta sheet fashion. Similar to enolase, this 
interaction does not affect Pnpase activity, probably due to its distance from the active 
site of Pnpase. The stoichiometric ratio between monomers of RNase E and Pnpase is 
1:1. The binding affinity between the 20 amino acids RNase E C terminal fragment and 
Pnpase trimers is about 0.9 µM as measured by ITC. Because RNase E is a tetramer in 
vivo, the affinity between full length RNase E and Pnpase could be much lower than 0.9 
µM (Nurmohamed, Vaidialingam, Callaghan, & Luisi, 2009a). 
Regulation of RNase E 
TRANSCRIPTIONAL REGULATION OF RNASE E 
Regulation of RNase E is crucial to cell survival given its essential role in processing 
rRNAs and decay of mRNA.  Rne is transcribed from three promoters, p1, p2 and p3. 
rne transcribed from any of these promoters on a single copy vector can support cell 
growth of an rne1018::bla deletion mutant(Maria C. Ow, Qi Liu, Bijoy K. Mohanty & 
Andrew, 2002) Measuring rne transcript levels and RNase E protein in mutants utilizing 
either the p1, p2 or p3 promoter only led to some intriguing findings: transcription from 
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either one of the two weak promoters (p2 and p3) resulted in low steady levels of rne 
transcript, but auto regulation (see below) was lost and therefore the transcript had a half-
life. However the RNase E protein level expressed from the weak promoter was reduced 
more than 10 fold compared to wild types. Moreover, cells with less than 20% of 
“normal” level of RNase E protein appeared to function properly in terms of mRNA 
decay, implying that under “normal” conditions, RNase E may be present in large excess.  
POST-TRANSCRIPTIONAL REGULATION OF RNASE E 
Extensive bioinformatics and genetics analyses have delineated the post-transcriptional 
control of rne mRNA. RNase E auto regulates its translation and hence its cellular 
activity by modulating the rne mRNA degradation rate. (Jain & Belasco, 1995) This auto 
regulation is achieved in cis via the first 361 nucleotides in the rne 5′ UTR. Despite the 
sequence divergence, the secondary structure of RNA in this region is well conserved 
among different bacteria species. This 361nt region can be further dissected into 3 hairpin 
(hp) loops and 3 single stranded regions located in between the hairpin loops. Deletion 
and substitution analysis revealed that hp2 and hp3 are core elements that mediate rne 
auto-regulation (Diwa, Bricker, Jain, & Belasco, 2000). Specifically, the 8 nucleotides 
internal loop located near the top of hp2 is essential for this regulation (Diwa & Belasco, 
2002). The role of hp2 was further elucidated in a recent study that showed that it binds 
to the N-terminal catalytic core of RNase E forming two different complexes (productive 
and unproductive). The productive complex facilitates cleavage elsewhere in the 
transcript. Three alanine mutations in RNase E (F57, R169 and N323) severely impair 
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hp2 binding. These mutations are located at the S1 RNA binding domain, 5′ sensor region 
and the DNase I region. However, one of the earliest studies on RNase E regulation 
claimed that auto-regulation is compromised when the central region (591-601aa) of 
RNase E is deleted, as demonstrated by the level of β- galactosidase activity from an rne-
lacZ transcriptional fusion, suggesting that alternative interaction sites may exist (Jain & 
Belasco, 1995). The importance of RNase E C-terminal half for its autoregulation was 
further illustrated by studies using the rneΔ610 mutant, which contains only the N-
terminal catalytic half of RNase E (i.e. 610 residues were deleted from the C-terminal). In 
this mutant, the processing of rne transcript is impaired. Specifically, the mutant very 
poorly cleaves within the rne 5′ UTR with only approximately one eighth of the wildtype 
cleavage efficiency is observed (Ow, Liu, & Kushner, 2000).  
POST-TRANSLATIONAL REGULATION OF RNASE E 
Another level of RNase E regulation occurs after translation. To date, three small proteins 
have been identified to modulate RNase E activity by binding to RNase E C-terminal 
region: RraA, RraB and the L4 ribosomal protein (Gao et al., 2006; Lee et al., 2003; 
Singh et al., 2009). These small proteins regulate the cleavage of a subset of transcripts 
by mechanisms that are not fully understood.   
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The Components of the RNA degradosome 
RHLB 
E. coli has five DEAD box proteins, which further belong to the DEXD/H protein family. 
DEXD/H proteins are mostly involved in DNA and RNA metabolism. The five DEAD 
box proteins are RhlB, RhlE, SrmB, CsdA and DbpA. Sequence alignments of these five 
proteins shows that: they share a common DEAD-box core (about 350aa), with various 
short N-terminal extensions (2-9aa) and different C-terminal extensions (70-290 aa). The 
short N-terminals have no known roles, whereas the extended C-terminals are thought to 
interact with other proteins and RNAs.  
Most of the DEAD box proteins in yeast are essential however, the DEAD box proteins 
in E.coli are not essential under common laboratory growth conditions. Even various 
combinations of double knockout mutants can grow, although csdA mutants display cold 
sensitivity. SrmB, CsdA and DpbA are involved in ribosome biogenesis whereas RhlB 
and CsdA participate in mRNA degradation. The role of RhlE remains unknown.  
As noted before, the RhlB protein contains an N-terminal DEAD box core which contains 
seven key conserved motifs (I, Ia, Ib, II, III, Q and GG), the C-terminal (267-421aa) 
domain which contains four motifs (IV, V, VI and QxxR) and an arginine-rich basic tail 
(398-421aa) (Iost & Dreyfus, 2006). 
The DEAD box proteins have two biochemical activities in vitro: RNA-dependent 
ATPase activity and ATP–dependent RNA helicase activity. The RNA-dependent 
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ATPase activity is believed to occur in a cycle in which ATP-bound protein binds RNA, 
followed by the conversion from ATP to ADP and subsequent release of RNA.  
Exogenous RNA is required for ATPase activity. The assay can be continuously 
monitored by the release of phosphate (Chandran et al., 2007a) or by coupling ATP 
hydrolysis to NADH oxidation (Cartier, Lorieux, Allemand, Dreyfus, & Bizebard, 2010).  
DEAD box proteins unwind only a few base pairs during each ATP hydrolysis cycle.  
Unlike non-DEAD box helicases, DEAD box helicases have very poor processivity 
because they cannot prevent the unwound region to re-anneal. Hence, DEAD box 
helicases can only unwind RNA helices within 10 base pairs or less, which corresponds 
to an energy barrier of approximately 20kcal/mol. (Iost & Dreyfus, 2006). The unwinding 
activity can be assayed by measuring the conversion of duplex RNA to monomers which 
are separated by electrophoresis. A continuous helicase assay has been developed 
recently by Cartier et al. using complementary oligonucleotides that are labeled with Cy5 
or Cy3 fluorophores at the 3′ or 5′ extremities (Cartier, Lorieux, Allemand, Dreyfus, & 
Bizebard, 2010).  
In contrast to the other four DEAD box proteins, RhlB does not have detectable activity 
on its own. Both the ATPase and helicase activity of RhlB are stimulated by binding to 
the RNase E protein fragment (628-843aa). As noted above, the interaction site of RhlB 
is situated at the C-terminal extension region of RNase E. However the Arginine-rich 
basic tail is not required for this interaction. The binding affinity between RhlB and 
RNase E (628-843) is in the 50nM range with a stoichiometric ratio of 1:1. The 
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interaction of RNase E and RhlB boost the RhlB ATPase activity by at least an order of 
magnitude. Saturating amounts of RNase E (628-843) fragment are able to increase RhlB 
unwinding activity by more than 5 fold (Chandran et al., 2007a). There is an important 
caveat that applies to this assay. The experiment was done under conditions that RNA 
substrate is much less than enzyme (1:100 folds or less) in order for the unwinding 
reaction to happen irreversibly, due to the poor processivity of helicases discussed above. 
ENOLASE 
Enolase is a glycolytic enzyme catalyzing the reversible dehydration of 2-
phosphoglycerate to phosphoenolpyruvate. It is a universally conserved enzyme found in 
all three domains of life. In E. coli, enolase is a 48 kDa protein composed of two 
domains. The N terminal domain (1-142aa) consists of three anti-parallel β sheets 
followed by four α-helices. Interestingly, the helical domain of Pnpase from S. 
antibioticus shares structural similarity with the first three α-helices in the N-terminal 
domain of enolase. This observation raises the possibility that the E. coli enolase can bind 
RNA. The enolase C-terminal principal domain (143-431aa) is an 8-fold TIM barrel 
structure albeit with an unusual topological organization. The active site is at the C-
terminal ends of the β strands of the barrel. The E. coli enolase is a dimer which requires 
two magnesium ions per subunit to function. In yeast, enolase binds DNA or RNA and 
this binding inhibits its catalytic activity. Whether this is true in E.coli waits testing 
(Kühnel & Luisi, 2001). 
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It should be stressed that only one tenth of the enolase in the cytoplasm is recruited to the 
RNA degradosome. Enolase binds to the unstructured region of RNase E C terminal 
domain described above. The segment C peptide inserts into the dimer interface. The 
RNase E interaction region on enolase is remote from its active site as demonstrated by 
the co-crystallized enolase and segment C structure (Chandran & Luisi, 2006), which is 
consistent with the previous finding that binding with RNase E does not affect enolase 
catalytic activity. The function of enolase in RNA degradosome is unclear. It has been 
proposed that enolase interaction with RNase E serves as a mediator to link the cellular 
energetic state with post-transcriptional regulation. As mentioned above, the RNase E 
CTD-enolase complex does not bind to RhlB even through it contains the RhlB binding 
site(Callaghan et al., 2004), which suggests that enolase might play a structural role in the 
RNA degradosome. 
PNPASE 
Pnpase is a dual-function enzyme that catalyzes a reversible reaction: as a phosphorylase 
it degrades RNA in the 3′ to 5′ direction to produce nucleotide diphosphates (NDPs); as a 
polynucleotide synthase it adds tails to 3′ end of RNA in a template-independent manner. 
Besides this reverse reaction, Pnpase also catalyze the exchange of the β-phosphate group 
of nucleoside diphosphate and free orthophosphate. Because phosphorylysis is a near 
equilibrium reaction, the direction of the reaction is largely dependent on the availability 
of phosphate: high concentration of phosphate favors the degradation whereas excess 
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amount of diphosphates and low phosphate concentration promotes the 3′ terminal 
oligonucleotide polymerase activity. 
Mutants devoid of Pnpase grow normally at typical laboratory culturing conditions, but 
display impaired growth at lower temperatures. In RNase II or RNase R mutants, Pnpase 
is indispensable. Moreover, a recent study showed that Pnpase is responsible for 
degradation of oxidized RNAs and thus relieves cells from oxidative challenges (Wu et 
al., 2009). 
Pnpase exists in all three primary kingdoms. The E.coli Pnpase is a homotrimer 
consisting of 78 kDa subunits. Each subunit is composed of five domains: the N-terminal 
contains two homologous RNase PH domains which serve as the structural core, linked 
by an all α-helix domain at the bottom; on top of this core structure sit two C-terminal 
RNA binding domains, KH and S1.  The core RNase PH where the active site is situated 
at is conserved, as is the overall donut ring structure that forms a central channel for 
catalysis. Interestingly, in eukaryotes the ring structure is conserved in the yeast and 
human exosome, however the exonucleolytic activity is hydrolytic rather than the 
phosphorolytic activity found in prokaryotes. It appears that the active site residues are 
located at the RNase PH core. Metals ion (magnesium or manganese) is required for 
activity; the all α-helical domain is also implicated in catalysis. Truncation mutants 
without the C terminal KH or S1 RNA binding domains still catalyze phosphorylysis, 
with a significant increase in Km and more importantly, lack of processivity. 
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In E. coli, Pnpase can be found in two complexes: the RNA degradosome where it binds 
to RNase E C terminal (segment D), or in the Pnpase-RhlB complex. The interaction site 
with RNase E is located at the periphery of the core ring structure, with affinity to the 
segment D peptide in the micromolar range and a stoichiometric ratio of 1 (protomer). It 
is noteworthy that the KH and S1 domain at the C terminal of Pnpase do not affect this 
interaction. In comparison, the binding between Pnpase and RhlB are much stronger 
(0.9µM for RNase E binding vs. less than 25nM for RhlB binding). Moreover, the 
interaction is independent of the RNase E C-terminal region (Liou, Chang, Lin, & Lin-
Chao, 2002). RhlB also shows functional interactions with Pnpase independent of RNase 
E. It unwinds duplex RNA for Pnpase to carry out phosphorylysis. Of particular 
relevance to this interaction, Pnpase requires 7-9 bases of single-stranded RNA at the 3′ 
end for binding (Carpousis, Luisi, & McDowall, 2009). 
The regulation of Pnpase is complex. There is a stable double stranded RNA structure in 
the 5′ UTR of the pnp mRNA, which prevents its processing. Following the disruption of 
the double strand structure by RNase III, the newly generated 3′ end is subject to Pnpase 
degradation. Once the stem in the 5′ UTR is destroyed, the pnp mRNA becomes sensitive 
to RNase E. An earlier model proposed that Pnpase binding to the 5′ UTR stem structure 
prevents translation thus making the mRNA vulnerable to degradation. However, recent 
work by Carzaniga et al. argued that translation is involved in Pnpase auto regulation.  
The role of Pnpase in its auto regulation is that, after RNase III step, it transforms a stable 
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RNA with 5′ stem structure into a 5′ single stranded RNA which is further degraded by 
RNase E in a Pnpase-independent manner (Carzaniga et al., 2009). 
As mentioned above, the level of NDP and phosphate determines the direction of the 
Pnpase reaction. It also has been proposed that adding nucleotides onto the 3′ tail of RNA 
can facilitate the phosphorylysis reaction given that Pnpse need a 3′ single strand 
“handle” no shorter than 7 bases long. Another layer of complexity in Pnpase regulation 
comes from the role of ATP.  It has been reported that ATP at concentration of 5mM or 
higher inhibits Pnpase activity in both directions. Pnpase-dependent tailing or 
degradation of RNA mainly occurs at low energy charge. When the ATP concentration is 
high, other enzymes may play more significant roles in RNA processing.  In that regard, 
in the Pnpase-RhlB complex or the RNA degradosome, RhlB as an ATP-dependent RNA 
helicase converts ATP to ADP as it unwinds RNA duplex, decreases the “local” ATP 
concentration of its proximate Pnpase and helps relievethis  inhibition (Del Favero et al., 
2008). 
RRAA, RRAB AND OTHER MINOR COMPONENTS IN RNA DEGRADOSOME 
Following its discovery about 16 years ago, the E. coli RNA degradosome has been 
characterized by many groups around the world. Besides the major components in the 
complex, several minor components have been found in sub-stoichiometric amount such 
as CsdA, PPK, GroEL, DnaK and Hfq. During bacterial adaptation to cold temperatures, 
the RhlB helicase is partly substituted with the cold shock helicase, CsdA thereby 
forming a “cold shock degradosome”. The mechanism underlying this degradosome 
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remodeling awaits more investigation. Likewise, a polyphosphate kinase (PPK) has also 
been co-purified in the degradosome complex, but the physiological significance of this 
enzyme is not known. GroEL and DnaK are chaperone proteins which may be recruited 
to assist proper protein folding of RNase E. The RNA binding protein Hfq is implicated 
in many small RNA regulation processes. Since no direct protein-protein interactions 
were detected with highly purified Hfq, the current understanding is that Hfq is recruited 
to the degradosome complex via mediating RNA. Hfq binding to small RNAs initially 
protects them from degradation and mediates their interaction with target mRNA in the 
translation initiation site. Upon repression of translation, both sRNA and mRNA are 
degraded by RNase E. In this respect, the recruitment of Hfq to the degradosome 
promotes cleavage of RNA that binds to Hfq (Worrall et al., 2008). 
Two protein inhibitors of RNase E, RraA and RraB (regulators of ribonuclease activity A 
and B) have been discovered by our group using genetic screens (Lee et al., 2003). In 
vivo studies demonstrated that these inhibitors can bind to the C-terminal domain of 
RNase E and remodel the structure of degradosome complex, consequentially affecting a 
large group of E. coli transcripts (Gao et al., 2006). Homologs of RraA exist in bacteria, 
Achaea and plants, whereas RraB homologs are found only in γ-proteobacteria. Of 
particular relevance to the current study, RraA and RraB both can inhibit the activity of 
RNase ES, a functional ortholog of RNase E from Streptomyces coelicolor. (Yeom et al., 
2008) Moreover, RraAV1, a homolog of E.coli RraA from Vibrio vulnificus that shares 
80% identity can effectively inhibit E.coli RNase E activity (Lee, Yeom, Sim, Ahn, & 
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Lee, 2009a). It is noteworthy that another inhibitor of RNase E, the ribosomal protein L4 
interacts with the degradosome to affect a set of 85 transcripts that are related to stress 
response (Singh et al., 2009).   
Microarray studies revealed drastic changes in the transcriptome of cells which over-
express RraA/RraB:  336 transcripts were stabilized by either RraA or RraB, 371 
transcripts were affected uniquely by the over-expression of RraA whereas 85 transcripts 
were stabilized only by RraB.  
Research Outline 
The discovery of RraA and RraB revealed a new mechanism for the global regulation of 
mRNA abundance. This work has raised several questions: First, why do such small 
inhibitory proteins exist in the genome? What is the physiological significance of these 
genes? Second, how does the binding of RraA or RraB affects the detailed kinetics of 
RNA hydrolysis by RNase E or in concert with other degradosome components?  I have 
combined genetics and biochemistry methods to address these questions. 
In chapter 2, I describe the transcriptional regulation of rraA and rraB.  In Chapter 3, I 
describe the reconstitution of the RNA degradosome by individually purified major 
components. The interactions between those components were demonstrated by 
immunoprecipitation.  In chapter 4, the inhibition RNase E-mediated hydrolysis of short 
and long, structured RNA substrates by RraA or RraB is detailed. The degradation of 
long, structured RNAs is shown to require a coordinated action of different degradosome 
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components. In the appendix, I have included preliminary results from proteomic 






















CHAPTER 2 TRANSCRIPTIONAL REGULATION OF RRAA AND 
RRAB. 
Introduction 
RraA (regulator of ribonuclease activity A), is an evolutionarily conserved 17.4-kDa 
protein with close homologs (>40% amino acid identity) in bacteria, Achaea, 
proteobacteria, and plants. RraA binds to RNase E with an equilibrium dissociation 
constant (KD) in the nano molar range and serves as a trans-acting modulator of the 
endonuclease activity of the enzyme (Gorna et al., 2010). High-affinity binding requires 
the C-terminal half region of RNase E, which acts as a scaffold for the assembly of a 
large multi protein complex called the degradosome (Gao et al., 2006; Gorna et al., 2010; 
Vanzo et al., 1998). RraA appears to interact with RNase E and RhlB and by doing so 
masks the enzyme′s binding site for RNA substrates (Gorna et al., 2010). Gene chip 
analysis revealed that the action of RraA results in a dramatic change in the global 
abundance of mRNAs in E.coli, affecting over 15% of all cellular transcripts. 
Importantly, the gene expression profile that is obtained upon over expression of RraA is 
distinct from that obtained upon depletion of RNase E or through the action of RraB, a 
second trans-acting RNase E inhibitor of E. coli (Gao et al., 2006). The rraA gene is 
located downstream of menA, which encodes a 1, 4-dihydroxy-2-naphthoic acid 
octaprenyltransferase that catalyzes the prenylation of the redox mediator menaquinone 
(Shineberg & Young, 1976). Transcription of menA appears to occur from a σ70-
dependent promoter. Earlier, Meganathan proposed that rraA (formerly designated 
menG) is transcribed from the menA promoter in a dicistronic mRNA (Meganathan, 
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1996).  However we demonstrated that rraA is transcribed predominantly from its own 
promoter (PrraA) located in the intergenic regions between menA and rraA genes. 
Transcription from PrraA is σ
s-dependent and is induced upon entry into stationary phase. 
Furthermore, we showed that the synthesis of RraA is regulated at the post-transcriptional 
level by RNase E, suggesting the existence of a feedback regulatory circuit whereby 
induction of rraA transcription occurs in a s-dependent manner and results in inhibition 
of RNase E activity, in turn decreasing the degradation rate of the rraA transcript (Zhao, 
Zhou, Kawarasaki, & Georgiou, 2006). 
RraB, previously annotated as YjgD in the NCBI database, is a 15.6 kDa protein that 
interacts with RNase E and inhibits RNase E endonucleolytic cleavages in E. coli. In 
contrast to RraA which has homologues in numerous bacterial genomes, RraB is only 
found in γ-proteobacteria, suggesting that the latter protein may have a more specialized 
role in modulating RNA degradation. Similar to RraA, RraB does not alter RNase E 
cleavage site specificity nor does it interact detectably with the substrate RNAs.  RraB 
also possesses similar affinity for RNase E as RraA.  However, RraB exhibits key 
differences in its mode of action and its effects on the transcript profile.  RraB interacts 
with residues 694-727 at the C terminal half of RNase E (Gao et al., 2006). Over 
expression of RraB from a high copy plasmid induces specific changes in degradosome 
composition that are distinct from those mediated by RraA over expression. Importantly, 
the action of RraB results in a dramatic change in the global abundance of mRNAs that is 
different from that obtained through the action of RraA (Gao et al., 2006). The existence 
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of two cellular proteins that exert differential effects on RNA decay via their interactions 
with RNase E and degradosome remodeling argues that modulation of RNA stability may 
be a mechanism for global control of transcript abundance in response to dynamic 
changes in the environment.  
The E. coli rraB gene is 417 bp in length and is located at 96.4 minutes on the 
chromosome, adjacent to argI which is transcribed from the opposite strand and codes for 
ornithine carbamoyltransferase I.  Here we show that rraB is transcribed from its own 
promoter (PrraB) which is divergent from the argI promoter and overlaps with the arginine 
repressor binding site (ARG box) (Makarova, Mironov, & Gelfand, 2001) located in the 
argI-rraB intergenic region. However we found no evidence that the promoter of rraB is 
regulated by the transcription factor ArgR or the availability of arginine.  A screen for 
transposon insertions that enhance the β-galactosidase activity from a Ф(PrraB-lacZ) 
transcriptional fusion led to the isolation of a glmS852::Tn5 allele that upregulated rraB 
transcription by about 5-fold. The glmS852::Tn5 allele resulted in a decrease in the 
cellular UDP-GlcNAc level to less than 50% of the level observed in the parental strain. 
Furthermore, β-galactosidase activity from an rne-lacZ fusion increases in the 
glmS852::Tn5 mutant. Since the rne-lacZ transcript is a substrate of RNase E, the 
increase in β-galactosidase activity indicates that the rne-lacZ fusion is stabilized as a 
result of a reduction in RNase E activity, presumably a consequence of enhanced 




Materials and Methods 
STRAINS AND PLASMIDS   
The strains, plasmids, and phage vectors used in this study are listed in Table 2.1. The 
plasmid pBAD30-glmS was constructed as follows:  the glmS gene coding sequence 
was amplified by PCR from genomic DNA of strain MC4100 using the following 
primers: glmS5 (5′-CGGCGGGGTACCAGGAGGTTACGATGTGTGGAATTGTTGG 
C-3′) and glmS3 (5′-CGGCCCAAGCTTTTACTCAACCGTAACCGATTTTGCCAGG 
TT-3′). The PCR product was digested with KpnI and HindIII and then ligated into the 
plasmid pBAD30 that was similarly digested. 




Description Reference or 
Source 





CAG51025 MC1061 φλ[rpoH P3::lacZ] ∆rseB nadB-




CJ1825 MC1061 (λez1)  (Gao et al., 2006) 
DHB4 (ara-leu)7697 araD139 _lacX74 galE galK 
rpsL phoR  (phoA)PvuII malF3 thi/F  lac-pro 
lacIq 
(Denisot, Le 
Goffic, & Badet, 
1991) 
EC-O  thi-1, relA1, ∆(pro-lac)X113[del = DE5] 
supE44 / F42-114(FTs) lac 
(Simons, Houman, 
& Kleckner, 1987) 
JCB570  MC1000, phoR zih12::Tn10 (Bardwell, 
McGovern, & 
Beckwith, 1991) 




& Georgiou, 2001) 
KS474 F-lacX74 galE galK thi rpsL(strR) 
∆phoA(Pvull) degP41(∆Pstl)::Ω kanR 
(Strauch, 1988) 
LZ001 {P90C, λ (-152 to -1 nt)-lacZ } This study 
LZ002 {P90C, λ (-152 to -1 nt)-lacZ, glmS852::Tn5 }  This study 
LZ003 {CJ1825, glmS852::Tn5} This study 
MC4100 F-, araD139, ∆ (argF-lac) U169, 
flbB(flhD)5301, deoC1, ptsF(fruA)25, relA1, 










MZB001 {EC-O, λ p0-lacZ } This study 
MZB002 {EC-O, λ (-239 to -1 nt)-lacZ }  This study 
MZB003  {EC-O, λ (-152 to -1 nt)-lacZ }  This study 
MZB004 {EC-O, λ (-239 to -153 nt)-lacZ }  This study 
P90C [ara ∆(lac-pro) thi] (Miller, 1972) 





pACYA184 ori, Ampr , glmS under pBAD 
promotor  
This study 
pSP417 pBR322 ori, Ampr  MCS sites (8 restriction 
sites) upstream of a promoter-less lacZ 
(Podkovyrov & 
Larson, 1995) 
pMZB002 {pSP417, (-239 to -1 nt)-lacZ } This study 
pMZB003 {pSP417, (-152 to -1 nt)-lacZ } This study 
pMZB004 {pSP417, (-239 to -153 nt)-lacZ } This study 
λRS 45 bla′-lacZsc imm21 ind + (Simons, Houman, 
& Kleckner, 1987) 
λRS74 placUV5-lacZ  imm21 ind + (Simons, Houman, 
& Kleckner, 1987) 
λMZB1 Same as λRS74, but containing the p0-lacZ 
fusion 
This study 




GROWTH CONDITIONS  
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Unless otherwise stated, cells were grown in Luria-Bertani broth (LB) under aeration at 
37°C, and growth was monitored by measuring the turbidity at 600 nm (A600).  Minimal 
media contained M9 salts (BD, SPARKS, MD), 50 µg/ml thiamine, 30 µg/ml proline, and 
0.2% glucose or 20µg/ml glucosamine-6-phosphate (GlcN-6-P) or 0.2% glycerol.  
Media were supplemented with antibiotics, as required (50 µg/ml ampicilin, 25 µg/ml 
kanamycin or 10 µg/ml chloramphenicol).   
 
RNA METHODS  
For reverse transcriptase-polymerase chain reaction (RT-PCR) analysis, total RNA was 
isolated with the RNeasy kit (Qiagen, Valencia, CA) and treated with RNase-free DNase 
(Ambion, Austin, TX).  50 ng of total RNA was subjected to RT-PCR analysis using the 
One Step RNA PCR kit (TaKaRa, New York, NY). Northern blots were performed using 
total RNA isolated from E. coli JCB570 grown in LB medium under aeration at 37°C.  
Samples were collected in one hour intervals throughout the exponential and stationary 
phases. 5 µg of total RNA per lane was loaded onto a denaturing gel containing 
formaldehyde, and then transferred to a positively charged nylon membrane (Hybond N+, 
Amersham, UK). The AlkPhos direct nucleic acid labeling and detection system 
(Amersham, UK) was used to synthesize the oligonucleotide probe specific to rraB gene 
(5′-AACAACCTGATGACGCATGGCA-3′). Hybridization, washing of the membranes, 
and detection of signals were carried out according to the manufacturer′s instructions.   
PRIMER EXTENSION  
29 
 
For primer extension, a 5′ 32P-labeled primer (5′CACCACTGACATTGCCTCCACCTTT 
-3′) was used in the RT reaction with 5 g of total RNA (purified using RNeasy Kit, as 
described above) and SuperScript III RNase H- Reverse Transcriptase (Invitrogen, 
Carlsbad, CA).  The primer extension products were separated on 6% polyacrylamide/7 
M urea gels. The dideoxy-DNA sequence ladder from the same primer was prepared 
using the fmol DNA Cycle Sequencing System (Promega, Madison, WI). 
REAL-TIME RT PCR   
Cells were grown in M9 minimal media with 0.2% glucose and collected at A600 =0.2. 
Total RNA was isolated with the RNeasy kit (Qiagen, Valencia, CA) and treated with 
RNase-free DNase (Ambion, Austin, TX).  Reverse transcription of 0.2 µg of total RNA 
was performed with random hexanucleotides and SuperScript III RNase H- Reverse 
Transcriptase (Invitrogen, Carlsbad, CA). The RT PCR was performed using primers (5′-
TCGTGATTTGCTGCGACATC-3′) and (5′-ACCTGGGCATCGATCAGATC-3′) for 
rraB gene in the experiment. Primers (5′-TCGAACAGGTGGCGTTAAATG-3′) and (5′-
GGAGCGCAAATGCAGACAT-3′) were used for dnaX gene as a control.  Real-time 
PCR reactions were performed using ABI Prism 7900 (Applied Biosystems) under 
universal cycling conditions (2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, 
and 1 min at 60°C).  The reaction mixture (20 µl) contained 2× SYBR Green PCR 
Master Mix (PE Applied Biosystems), 10 pmol of forward and reverse primers, and 5l of 
cDNA (0.1-10 ng).  Sequence-specific standard curves were generated by using serial 
dilutions of cDNA and the quantity of rraB cDNA was normalized relative to dnaX 
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cDNA in each sample.  Cycle threshold (CT) values were determined by automated 
threshold analysis with ABI Prism version 2.3 software.  Each experiment was 
performed at least three times with two independent RNA preparations. 
LACZ FUSIONS  
PCR amplification was used to generate DNA fragments between -239 to -1 nt in rraB.  
These fragment were cloned upstream of the lacZ gene in the multicopy transcriptional 
fusion vector, pSP417.  The lacZ fusions were transferred into λRS45, and the negative 
control in pSP417 was transferred into λRS74 via double recombination(Simons, 
Houman, & Kleckner, 1987).  Blue plaques containing the recombinant lambda phages 
were isolated and used to lysogenize strain EC-O (Δlac) to generate strains MZB001 to 
MZB004. All lysogens were tested for mono-lysogenization by PCR. A similar approach 
was employed for the transfer of the Ф (-152 to -1 nt) rraB-lacZ fusion into the strain 
P90C (Δlac) to generate LZ001. 
 To measure β-galactosidase activity, cultures were grown with aeration at 37°C in 
M9 medium overnight and subcultured into the fresh medium. To detect the effect of 
tryptophan or arginine limitation, cultures were grown in the appropriate media as 
described in supplementary material.  Aliquots were collected, centrifuged at 4°C and re 
-suspended in an appropriate volume of ice-cold Z buffer (60 mM Na2HPO4, 40 mM 
NaH2PO4, 10 mM KCl, 1 mM MgSO4; pH 7.0) (Miller, 1972) to give OD600 in the 
range from 0.6 to 0.9.  β-galactosidase activities were determined from at least three 




TRANSPOSON MUTAGENESIS  
50 ng of transposome (EZ-Tn5TM, Epicentre, Madison, WI) was electroporated into 50 
µl (108 cells) competent cells of E.coli LZ001 strain. Transformed cells were grown on 
LB plates containing 25 µg/ml kanamycin and 25 µg/ml X-gal and incubated at 37oC 
overnight. Out of about 32,000 colonies that were screened, 6 showed an intense blue 
color consistently. Of these, one strain gave markedly higher β-galactosidase activity in 
liquid cultures. Genomic DNA from this clone was extracted using DNeasy kit (Qiagen, 
Valencia, CA), fragmented by EcoRI digestion and self-ligated using T4 DNA ligase 
(Roche, Switzerland). The ligation product was transformed into the E. coli pir+ strain 
BW21116 (Haldimann, Daniels, & Wanner, 1998) and kanamycin resistant colonies were 
selected. Those colonies contained plasmids formed by circularized ligation products, 
made from partially digested genomic DNA containing the R6Kγori and kanamycin 
resistance cassette. Plasmid DNA was purified and sequenced using the primers R6KAN-
2 and KAN-2 FP-1 provided by the EZ-Tn5TM Kit.  
 
DETERMINATION OF UDP-GLCNAC CONCENTRATION  
The UDP-GlcNAc concentration in strains LZ001 and LZ002 was determined by HPLC.  
Cultures were grown in M9 minimal media to an A600 of 0.2 to 0.3 and the cell pellets 
were collected and deproteinized with 5% trichloroacetic acid (TCA). The supernatants 




until further use.  UDP-GlcNAc was determined by HPLC using a CarboPac PA1 
column (250x4mm, Dionex) and a guard column (4x50mm) of the same material. 
Analytes were eluted using an ammonium acetate gradient (Zhang, Zhou, Bao, & Liu, 
2006) with detection at 262 nm. Under these conditions UDP-GlcNAc elutes with a 
retention time of 15.3 min (Namboori & Graham, 2008). The UDP-GlcNAc 
concentrations in cell extracts were calculated from the integrated peak areas using 
appropriate standards and the data was normalized based on total cell dry weight 
measured according to Namboori et al. (Namboori & Graham, 2008). Experiments were 
carried out in triplicates with independently prepared cell extracts. 
Results 
IDENTIFICATION OF THE PRRAB PROMOTER 
Analysis of the DNA sequence upstream of the rraB gene using the GENETYX-MAC 
(11.2.5) software suggested the existence of two putative promoters that match the δ70 
consensus -35 and -10 sequences. The proximal promoter has -35 and -10 sequences 
centered at 128 and 104 nucleotides, respectively, upstream of the rraB translation start 
site (Figure 2.1A).  The upstream region containing this putative promoter sequence is 
well conserved (≥80% sequence identity) among γ-proteobacteria including Escherichia 
coli, Shigella flexneri and Salmonella enterica. (Figure 2.1B).    
Northern blot analysis with rraB-specific probes revealed that the rraB mRNA is 
transcribed throughout the exponential and stationary phase (Figure 2.2).  A single band 
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corresponding to a transcript of approximately 500 bases was detected suggesting that 
transcription of rraB occurs from the putative proximal promoter and gives rise to a 
monocistronic mRNA.  Primer extension of RNA isolated from E. coli JCB570 revealed 
a single rraB transcript that is initiated at a T residue 88 bp upstream from the ATG 




Figure 2.1:  Identification of PrraB (A) Two pairs of putative promoters that 
match the δ70 consensus -35 and -10 sequences were identified using GENETYX-MAC 
11.2.5.  The arginine repressor binding sites (ARG boxes) are shown boxed, the argI 
promoter sequence is underlined and the rraB coding sequence is highlighted.  (B) 
Multiple sequence alignment of the argI-rraB intergenic sequence:  Abbreviations:  
B171, Escherichia coli B171, O157:H7-1, Escherichia coli O-157, K12, Escherichia coli 
K-12, CFT073, Escherichia coli CFT073. The transcription start codon, upstream 
putative -10 site, proximal -35, and -10 sites are shown in boxes.  (C) Primer extension 
35 
 
analysis. Asterisk and arrow showed transcription initiation site and the reverse 
transcription product respectively. 
 
The promoter activity of PrraB was further analyzed using lacZ transcriptional fusions. 
The different regions upstream of rraB extending up to the putative distal promoter as 
shown in Figure 2.3A, were amplified by PCR and cloned upstream of the lacZ gene in 
the low copy transcriptional fusion vector, pSP417 resulting in plasmids pMZB002 {Ф (-
239 to -1) rraB-lacZ}, pMZB003{Ф(-152 to -1) rraB-lacZ}, and pMZB004 {Ф (-239 to -
153) rraB-lacZ }. To rule out the possibility that differences in the β-galactosidase 
activity expressed from the above transcriptional fusions might be partially due to 
plasmid copy number effects, the lacZ fusions were inserted into the chromosome. 
(Simons, Houman, & Kleckner, 1987) First, the lacZ fusions were transferred into either 
λRS74 or λRS45 via a double recombination event and then E. coli EC-O was 
lysogenized with the recombinant lambda phages to generate strains carrying a single 
copy of the respective promoter-lacZ fusion.  As shown in Figure 2.3B, strain MZB003 
{EC-O, λФ(-152 to -1) rraB-lacZ }, encoding the rraB upstream region that includes the 
proximal promoter fused to lacZ, showed similar levels of β-galactosidase activity to 
those observed in MZB002 {EC-O, λФ (-239 to -1) rraB-lacZ}, which contains a fusion 
to the rraB upstream region including both the proximal and the distal putative promoter 
sequences.  In contrast, MZB004 {EC-O, λФ (-239 to -153) rraB-lacZ} containing a 
fusion to the rraB upstream region that lacks the proximal promoter gave background 
activity. These results further support the notion that rraB is transcribed from the 
 
proximal promoter, PrraB. In the studies described below, the transcriptional fusion, 
152 to -1) rraB-lacZ is now designated as 
Figure 2.2: Northern Blotting of rraB gene in strain JCB570 (upper right panel), total 
RNA (lower right panel) and growth curve with sampling times for RNA isolation (left 
panel). The rraB transcript is about 500 bases in length. 
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Figure 2.3: Transcriptional LacZ fusions (A) Schematic of the transcriptional rraB –lacZ 
fusions used in this study.  (B) and (C): β-galactosidase activities in MZB001, MZB002, 
MZB003 and MZB004 cells.  Cells were grown in LB under aeration at 37°C, and 
harvested in either log phase (A600 = 0.5, shown in black) or stationary phase (A600 = 1.6, 
shown in white).  Samples were normalized by A600 and enzymatic activities were 
measured in Miller units.  The data presented are the average of at least three 




The expression of the rraA gene was previously shown to be induced in stationary 
phase.(Zhao, Zhou, Kawarasaki, & Georgiou, 2006) Northern blot analysis (Figure 2.2) 
and measurements of the β-galactosidase activity expressed from the Ф(PrraB-lacZ) 
fusion in exponential and stationary phase cells revealed that the transcription level of 
rraB is not affected by the growth phase (Figure 2.3C). The E. coli rraB gene is adjacent 
to argI which is transcribed from the opposite strand and encodes ornithine 
carbamoyltransferase I, a key enzyme in arginine biosynthesis.  Earlier microarray 
analyses had indicated that the expression of rraB is correlated with that of argI and it is 
increased upon arginine deprivation (Khodursky et al., 2000, Ramelot et al., 2003).  
Interestingly, the genomic organization of rraB and argI is conserved in other γ-
proteobacteria such as S. enterica and Y. pestis. In V. cholerae, the rraB homologue, 
VC0424 is located in a similar head-to-head orientation with VC0423 (Figure 2.4), which 
codes for arginine deiminase that is involved in arginine catabolism. Inspection of the 
nucleotide sequence in the argI-rraB intergenic region revealed the presence of a putative 
arginine repressor (ArgR) binding site (ARG box), which consists of two neighboring 18-
bp palindromic sequences separated by three nucleotides (Figure 2.1A). The influence of 
arginine availability on rraB transcription was examined as follows: First, excess arginine 
(20 mM) was added to cultures growing in minimal medium. Second, cells grown in LB 
were transferred into medium without arginine for two hours to achieve transient arginine 
starvation. Neither excess nor depletion of arginine exerted any significant effect on the -
39 
 
galactosidase activity of MZB003 cells carrying the Ф(PrraB-lacZ) fusion (data not 
shown).  
 
Figure 2.4 Multi-Genomes ortholog analysis (http://www.biocyc.org) showing the head-
to-head alignment of rraB (yjgD) and argI conserved in E. coli and related bacteria.  
STY4807 in S. Typhi coding for ornithine carbamoyltransferase subunit I and VC0423 in 
V. cholera coding for arginine deiminase, are both involved in L-arginine metabolism 
pathways. 
 
Khodursky et al. reported that the expression of the rraB gene is repressed in response to 
tryptophan starvation (Khodursky et al., 2000). To evaluate the effect of tryptophan on 
the transcriptional activity from PrraB, we determined the β-galactosidase activity in 
MZB003 grown either in minimal media with excess tryptophan or under conditions of 
tryptophan starvation (data not shown).  None of these conditions affected the level of 
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β-galactosidase activity expressed from the Ф(PrraB-lacZ) fusion, indicating that PrraB 
promoter does not respond to tryptophan availability.   
TRANSPOSON MUTAGENESIS  
Transposon mutagenesis and screening for colonies displaying a higher level of -
galactosidase activity from the Ф(PrraB-lacZ) fusion were employed to isolate 
chromosomal lesions that might result in increased transcription from the PrraB. First, the 
Ф(PrraB-lacZ) fusion was transferred into the Δlac strain P90C resulting in strain LZ001, 
which gave pale blue colonies on LB agar plates containing 25 µg/ml X-gal. Following 
transposon mutagenesis using the EZ-Tn5TM transposome, six dark blue colonies were 
isolated from approximately 32, 000 colonies tested.  One of these colonies, designated 
LZ002, reproducibly produced the dark blue phenotype on X-Gal plates and also resulted 
in higher β-galactosidase activity in lysates from cells grown in liquid cultures.  
Genomic DNA from LZ002 was purified, digested with EcoRI, self-ligated and 
transformed into the E. coli pir+ strain BW21116 (Haldimann, Daniels, & Wanner, 
1998). The colonies formed on kanamycin plates carry plasmids made of circular 
genomic DNA fragments containing the Tn5 insertion. Plasmid DNA was isolated and 
the site of the transposon insertion was determined by DNA sequencing using 
transposon-specific primers. This analysis revealed that the transposon insertion occurred 
at 391, 0475 bp of the E. coli chromosome, which corresponds to the nucleotide 852 in 
glmS (Figure 3A). glmS encodes the enzyme L-glutamine: D-fructose-6-phosphate 
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amidotransferase (EC 2.6.1.16), also known as GlcN-6-P synthase.  GlcN-6-P synthase 
is a critical metabolic control point in the biosynthesis of amino sugar-containing 
macromolecules. It catalyzes the first committed step in the pathway leading to the 
formation of UDP-GlcNAc, a universal GlcNAc donor for the biosysthesis of cell walls, 
extracellular matrix, glycolipids and the protein posttranslational modifications 
(Milewski, 2002; Namboori & Graham, 2008).    
 The glmS852::Tn5 strain LZ002 grew slower than the parental wild-type strain in 
both rich (data not shown) and minimal media (Figure 2.5B). LZ002 displayed four-fold 
higher β-galactosidase activity than its isogenic control LZ001 in exponential phase 
(Figure 2.5C). Consistent with this result, the steady-state level of rraB mRNA as 
determined by real time RT-PCR was five-fold greater in glmS852::Tn5 cells compared 
to the parental strain LZ001(Table 2.2). To rule out the possibility that the increase in 
transcription from the PrraB promoter in cells containing the glmS852::Tn5 allele was 
related to their lower growth rate, I also compared the steady state rraB transcript level in 
strain Mjf256.10 (Faulkner, Veeravalli, Gon, Georgiou, & Beckwith, 2008) which grows 
at a comparable rate to LZ002 as a result of mutations that affect the cytoplasmic 
reduction pathways and are unrelated with UDP-GlcNAc metabolism. In contrast to the 
5-fold increase observed in the rraB mRNA levels of LZ002 relative to its parental strain, 
the rraB transcription in strain Mjf256.10 was slightly lower (67%) than that of its 









 To test whether specific complementation of glmS can reverse the effect of 
glmS852::Tn5 mutation, glmS was cloned into a low-copy plasmid, pBAD30, and 
expressed from an arabinose-inducible promoter.  When grown in M9 minimal medium 
supplemented with 0.2% glucose but without arabinose, LZ002 cells transformed with 
pBAD30-glmS exhibited similar β-galactosidase activity as LZ002 cells without plasmid 
(data not shown). However, when the strain LZ002 containing pBAD30-glmS were 
grown in the presence of 0.2% of arabinose, the β-galactosidase activity was reduced to 
the level observed in the parental strain LZ001. Under these conditions cells containing 
pBAD-glmS accumulate GlmS at the level comparable to that obtained from the 
chromosomal copy of glmS in the parental Stain LZ001, as monitored by Western 
blotting using anti-GlmS antibodies (data not shown). As a control, transferring the 
empty pBAD30 plasmid did not reverse the effect of glmS852::Tn5 mutation under both 
growth conditions (Figure 2.5D). Moreover, consistent with the physiological role of 
GlcN-6-P synthase, addition of its enzymatic reaction end product (GlcN-6-P) to LZ002 
cells resulted in normal growth rate (Figure2.6) and basal β-galactosidase activity (Figure 
2.5C). Finally, the glmS852::Tn5 allele did not affect the LacZ activity from a 
chromosomal  (PrraA-lacZ) fusion  (Zhao, Zhou, Kawarasaki, & Georgiou, 2006) 
indicating that the impairment of glmS specifically enhances the transcription of rraB but 





Figure 2.5:  A transposon insertion in 
transposon insertion in the glmS
promoter glmUp1. (B) Growth curve of strains LZ001 (in solid line) and LZ002 
(glmS852::Tn5, in dashed l
galactosidase activities in strains LZ001(white) and LZ002 (black) in the presence or 
absence of 20 µg/ml GlcN-6-
at A600 = 0.2-0.3. (D). Complementa
pBAD-glmS. E.coli strains LZ001 (white) and LZ002 (black) transformed with plasmid 
pBAD30 or pBAD30-glmS as indicated were grown overnight in M9 with 0.2% glucose 
and subcultured into fresh M9 media with 0.2% 
arabinose was added. Cells were harvested 2 hours after induction and the 
activity was determined.   
Figure 2.6 Growth curve of 
M9 medium supplied with 20µg/ml GlcN
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transduction. None of them shows significant effect the PrraB activity based on -
galactosidase activity (Figure 2.7). 
 
Figure 2.7  β-galactosidase activities from strain LZ001 and its mutant strains carrying  
deletions in genes that induce envelope stress. Mutations in dsbA, degP or in  degS and 
rseB were transferred into LZ001 by P1 transduction from different strains (Table 1). -
galactosidase activities were measured in cells grown in M9 media with 0.2% glucose 
and harvested at A600 = 0.2-0.3. 
 
EFFECT OF GLMS852::TN5 MUTATION ON RNE-LACZ ACTIVITY  
RNase E autoregulates its expression in cis by cleaving its own mRNA near the 5′ UTR 
region. Consequently, the production of RNase E is inversely affected by changes in the 
catalytic activity of the enzyme. Strain CJ1825 (MC1060, λez1) contains a chromosomal 
fusion of truncated rne gene (the 5′ UTR of rne gene, and N-terminal 181 codons) linked 
to the lacZ reporter. Due to the self-cleavage of the rne-lacZ transcript, a higher β-




































versa (Jain & Belasco, 1995). We previously showed that over expression of RraB 
conferred increased β-galactosidase activity from the rne-lacZ of this strain (Gao et al., 
2006). We examined whether the glmS852::Tn5 allele and the resulting upregulation of 
rraB also inhibit RNase E, in turn give rise to a higher β-galactosidase activity. The 
glmS852::Tn5 mutation was introduced into strain CJ1825 via P1 transduction to give 
rise to E.coli LZ003. The glmS852::Tn5 allele in E.coli LZ003 also caused a growth 
defect in both rich and minimal media (data not shown). -galactosidase activity was 
increased by more than 2-fold in LZ003 compared to wild type (Figure2.8). Notably the 
observed increase in β-galactosidase activity from the rne-lacZ fusion in strain LZ003 is 
comparable to that obtained through over expression of rraB transcribed from a trc 
promoter in plasmid pTrc99a (Gao et al., 2006). 
 
Figure 2.8  The glmS852::Tn5 allele reduces β-galactosidase activity from the rne-lacZ 
fusion.  E. coli strains CJ1825 and LZ003 were cultured in LB media. At log phase, cells 




In earlier studies we showed that RraB is a protein inhibitor that interacts with RNase E, 
modulates the composition of the degradosome and affects the ability of the RNA 
degrading machinery to recognize and cleave numerous RNAs.  Studying the regulation 
of rraB gene expression is important for understanding its physiological significance.  
Primer extension and lacZ transcriptional fusion experiments demonstrated that rraB is 
transcribed from its own promoter (PrraB) located 88 bp upstream from the translation 
start codon. Northern blot analysis and lacZ transcriptional fusion experiments 
demonstrated that, unlike rraA, the transcription of rraB is not growth phase-dependent. 
The E. coli rraB and its homologues in other bacteria, such as S. typhimurium, Y. pestis 
and V. cholerae, are arranged in a head-to-head alignment with the adjacent gene, argI. 
Simultaneous regulation of two divergent promoters by ArgR has been described for a 
number of adjacent gene pairs such as argE and argC or argG and metY. (Krin, Laurent-
Winter, Bertin, Danchin, & Kolb, 2003) While the existence of a putative ArgR binding 
site suggests that transcription from PrraB might be regulated by the availability of L-
arginine, we observed that the transcriptional activity as determined from the level of β-
galactosidase, was unaffected by the presence or absence of L-arginine. Similarly we 
found that transcription of PrraB is not affected by tryptophan starvation, inconsistent with 
earlier microarray analysis (Khodursky et al., 2000, Ramelot et al., 2003). Because in 
microarray studies the steady state mRNA level is the outcome of both transcriptional 
regulation and post-transcriptional effects, the observed correlation between the mRNA 
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levels of tryptophan/arginine metabolic genes and rraB in those studies could be related 
to rraB mRNA itself or other post transcriptional regulations, rather than its promoter.    
Transposon mutagenesis was employed to identify transcriptional regulators of rraB 
promoter by screening for enhanced β-galactosidase activity from the Ф(PrraB-lacZ) 
transcriptional fusion. Screening of over 30,000 colonies led to the isolation of one clone 
(LZ002) which displayed 4 fold higher β-galactosidase activity, and moreover, a 5-fold 
greater steady state accumulation of the rraB transcript. Surprisingly, the transposon 
insertion was located in the glmS gene encoding the essential enzyme GlcN-6-P synthase, 
a ubiquitous protein, present in all known organisms. Both prokaryotic and eukaryotic 
enzymes contain an N-terminal glutamine-binding domain and a C-terminal D-fructose-
6-phosphate-binding domain, with the eukaryotic enzymes having additional 40–90 
amino acid residues linking the two. Except for the eukaryotic linker region, the N-
terminal and C-terminal domains are highly conserved, including all the residues 
involved in substrate binding and catalysis (Milewski, 2002). We found that in strain 
LZ002, the Tn5 transposon was inserted in the C-terminus after the conserved N-terminal 
domain. Upon further inspection, we noticed the existence of a putative start codon at the 
3 of Tn5, which is preceded by an AU rich sequence 15 nt upstream that might serve as 
a ribosomal binding site for the translation of a chimera comprising the C-terminal part of 
GlmS. According to this hypothesis, the transposon insertion might result in the synthesis 
of two GlmS polypeptides, one comprising the N-terminal 284 amino acids and the 
second comprising amino acids 285-620. Early studies of GlmS showed that 
49 
 
chymotrypsin cleaves this protein at Tyr240 within a flexible loop to produce an N-
terminal glutamine hydrolase domain and a C-terminal fructose-6-phosphate isomerase 
domain; however the reconstituted protein fragments do not catalyze the full GlcN-6-P 
synthase reaction (Denisot, Le Goffic, & Badet, 1991). The additional amino acids 241-
284 in the present construct form α-helices 7 and 8, which could interact with helices of 
the isomerase fragment to form a stable SIS domain (Teplyakov, Obmolova, Badet, & 
Badet-Denisot, 2001). Interaction between the two subunits would form an ammonia 
channel, conferring weak glucosamine-6-phosphate synthase activity, in turn enabling the 
synthesis of essential UDP-GlcNAc. Because the cellular level of GlcN-6-P is beyond 
detection limit, to evaluate this hypothesis we determined the cellular concentration of 
UDP-GlcNAc in the glmS852::Tn5 strain LZ002 and its isogenic control LZ001 using 
HPLC (Namboori & Graham, 2008). As expected, LZ002 was found to synthesize UDP-
GlcNAc, but at a reduced level.  The concentration of UDP-GlcNAc in mutant strain 
was 53% lower than that in the parent strain (LZ002 versus LZ001, respectively) with a 
statistically significant difference of p<0.01 (2 tailed t-test).  
These results indicate that these cells have a functional GlcN-6-P synthase, possibly 
resulting from the translation of the C-terminal fragment, which in combination with the 
N-terminal polypeptide can reconstitute the active enzyme. Regardless of the mechanism 
that mediates the synthesis of GlcN-6-P, our results indicate that the transcription of rraB 
is modulated either by GlcN-6-P or by other metabolites derived from GlcN-6-P. This 
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effect is not the result of the reduced growth rate conferred by the glms852::Tn5 allele, 
nor does it affect the other RNase E inhibitor rraA, indicating that it is specific to rraB. 
As the enzyme catalyzing the first committed step of the UDP-GlcNAc pathway that 
provides the building blocks for the formation of cell wall macromolecules, GlcN-6-P 
synthase is an obvious point of metabolic control.  According to Collins et al. (Collins, 
Irnov, Baker, & Winkler, 2007), in B. subtilis, the 5′ UTR of the glmS messenger RNA 
contains a metabolite-sensing ribozyme. Binding of GlcN-6-P to the ribozyme stimulates 
autocatalytic site-specific cleavage near the 5′ of the transcript, resulting in the 
degradation of the transcript by RNase J1. Interestingly, RNase J1 is the 
endoribonuclease in B. subtilis with functional homology to RNase E in E. coli except 
that RNase J1 specifically cleaves transcripts with 5′ hydroxyl groups (Collins, Irnov, 
Baker, & Winkler, 2007). Kalamorz and Reichenbach (2007) reported that the regulation 
of glmS by GlcN-6-P in E. coli differs substantially from B. subtilis: in E. coli, when the 
intracellular GlcN-6-P concentration decreases, the short form of small RNA GlmY 
(GlmY*) accumulates and acts to stabilize a second small RNA, GlmZ, which is a 
homolog of GlmY. GlmZ is derived from the processing of the glmUS primary transcripts 
by RNase E and can stabilize glmS trancripts in concert with protein YhbJ (Kalamorz, 
Reichenbach, März, Rak, & Görke, 2007; Reichenbach, Maes, Kalamorz, Hajnsdorf, & 
Görke, 2008). Moreover, the glmS mRNA generated by RNase E from glmUS transcript 
is highly susceptible to poly (A)-dependent degradation (Joanny et al., 2007). We found 
that the glmS852::Tn5 allele increased rraB transcription, thereby lowering the RNase E 
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activity. These findings raise the possibility that upregulation of rraB in response to 
changes in metabolites of the GlcN-6-P pathway results in a reduction in RNase E 
activity, which in turn affects the processing of the glmUS primary transcripts. Thus, as 
with other post-transcriptional mechanisms of regulation, RraB may facilitate rapid 
alterations in RNA decay and/or processing in response to specific environmental stimuli 
such as reduced cellular levels of GlcN-6-P. The mechanism by which mutations that 
reduce GlcN-6-P synthase activity affect RraB expression and its detailed effect on the 
processing of the glmUS transcript are subjects of on-going studies.  
Part of this chapter is adopted from a previous publication: 






CHAPTER 3 RECONSTITUTION OF RNA DEGRADOSOME IN 
VITRO 
Introduction 
The RNA degradosome was discovered in 1994 by Carpousis et al. during the 
purification of RNase E.  The major components of this complex were shown to be 
RNase E, RhlB, Pnpase and Enolase.  Since then this complex has been the subject of 
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intensive study regarding its organization, structure and function. The mostly 
unstructured C terminal portion of RNase E serves as a platform where the degradosome 
is assembled. Using C terminal fragments of RNase E, the binding site of RhlB, Pnpase, 
and Enolase have been mapped. Ben F. Luisi et al. have solved the structures of each of 
these enzymes in the presence of their corresponding RNase E binding peptides. 
Structural information along with kinetic analysis revealed cooperativity effects between 
these components. This information was summarized in Chapter 1 of this dissertation.  
The majority of earlier studies were performed using pulled down complexes or 
fragments of proteins.  This is because the C terminal of RNase E is highly unstructured 
and susceptible to degradation during purification. To reconstitute the E.coli RNA 
degradosome, Worrall and Gorna et al. used modular coexpression vectors, with one 
plasmid containing RNase E and RhlB and, a second plasmid containing Enolase and 
Pnpase.  Using this method, all four components of the degradosome could be expressed 
and purified, effectively protecting the C-terminal. This approach has several 
shortcomings: First of all it is not possible to rule out the presence of truncated RNase E 
in these preparations; second the purified complex contains contaminating OmpT; third 
the complex may also contain RNA impurities; finally the co-elution of all four 
components does not allow kinetic analyses with different ratios of individual enzymes 
(Worrall et al., 2008).  
To this end, we have cloned expressed and purified the four major components of the 
RNA degradosome. Proteolysis was reduced by employing a denaturing purification 
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technique. Immunoprecipitation experiments showed that the refolded proteins were able 
to re-form a complex in vitro. All four components of the RNA degradosome were 
produced at biochemical relevant amounts and satisfying purity for future kinetic assays. 
Furthermore, the interaction between different components was determined. This chapter 
describes the biochemical evidence of an in vitro degradosome formation and the 
functional study of such complex with regard to RNase E inhibitors RraA and RraB is the 
subject of chapter 4. 
Materials and Methods 
BACTERIAL STRAINS, PLASMIDS AND GROWTH CONDITIONS 
The plasmids used in this study are listed in Table 3.1. The C-terminal His-tagged 
truncated RNase E expression plasmids were constructed as follows: rne gene fragments 
were PCR amplified. PCR products were digested with BsaI/Xhol and cloned into 
pET28(a) as previous described (Gao et al., 2006). The C-terminal SPA tagged 
degradosome components: rhlB, pnp and eno were PCR amplified from an E. coli SPA-
Tagged Strain (Open Biosystems, AL), restriction enzyme digested using NdeI and 
HindIII moved into the pET21(a) expression vector. The rraA and rraB genes were PCR 
amplified from genomic DNA of wild type E.coli strain JCB570 (Zhao, Zhou, 
Kawarasaki, & Georgiou, 2006), subjected to digestion with NdeI/BlpI and cloned into 
pTrc99A with N terminal 6xHistidine tags. 
Table 3.1  Plasmids used in this study 
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plasmids Description Reference or 
Source 
pET28(a) fl ori, Kan r T7 expression vector, C-terminal 




rne845 under  T7lac promoter in pET28(a) This study 
pET28(a)- 
Rne1045 
rne1045 under  T7lac promoter in pET28(a) This study 
pET21(a) fl ori, Amp r T7 expression vector Novagen 
pET21(a)-
Eno-SPA 
eno-SPA under  T7lac promoter in pET21(a) This study 
pET21(a)-
RhlB-SPA 
rhlB-SPA under  T7lac promoter in pET21(a) This study 
pET21(a)-
Pnp-SPA 
pnp-SPA under  T7lac promoter in pET21(a) This study 






rraA under trc promoter with N terminal 6x 




rraB under trc promoter with N terminal 6x 




T7 promoter sequence followed by RNA1 
cDNA template cloned with flanking EcoRI 
sitesin pUC ori plasmid, KanR 
This study 
PROTEIN EXPRESSION AND PURIFICATION  
For purification of truncated RNase E proteins, pET28(a) plasmids harboring appropriate 
gene fragments were transformed into the E. coli strain BL21(DE3). Bacteria cultures 
were grown in TB (Terrific broth) media at 37 °C to optical density (measured at A600) of 
approximately 0.5. Protein expression was induced with 1mM isopropyl--D-
thiogalactopyranoside (IPTG), and then cells were incubated for an additional 4-6 hours 
at 37 °C. The RNase E (residues 1-1045) protein with a C-terminal Histidine tag was 
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purified under denaturing conditions using the Ni2+-nitrilotriacetic acid-agarose (Qiagen, 
CA) affinity column as follows: Cell pellets were suspended in denaturing lysis buffer 
(100 mM NaH2PO4, 8M Urea, and 10 mM Tris-HCl, pH 8.0) with 0.5% TritonX-100. 
Complete protease inhibitor cocktail tablets (Roche, IN) were added to all purification 
buffers according to the manufacturer′s instructions. The 10x cell resuspensions were 
passed through a French press (Thermo electron, MA) twice at 20,000 psi to promote cell 
lysis. The cell lysates were clarified by centrifugation and filtration. Filtered supernatants 
were mixed with Ni2+-nitrilotriacetic acid-agarose previously charged and equilibrated 
with lysis buffer with 10mM imidazole. Following binding for 3 hours at room 
temperature, the slurry was packed into a column and washed with 10 column volumes of 
lysis buffer with 10 mM imidazole. An imidazole concentration gradient (in lysis buffer) 
ranging from 25mM to 250mM was applied for protein elution. The majority of the 
RNase E protein eluted at concentrations between 100 and 250mM imidazole. The eluant 
was then dialyzed into RNase E storage buffer (50mM Tris-HCl, 1mM EDTA, 500mM 
NaCl, 20% (v/v) glycerol, 0.5% Triton X -100, and 1mM DTT) at 4 ºC overnight. The 
refolded protein was concentrated by Amicon Ultra Ultracel-100K centrifugal filter. 
(Millipore, MA). 
The C-terminal SPA tagged Pnpase was purified from BL21(DE3) strains carrying 
pET21a-Pnp-SPA construct using anti-FLAG M2 beads (Sigma, MO) according to 
manufacturer′s instructions. The eluted protein (in Glycine Tris-HCl buffer with protease 
inhibitor) was dialyzed into RNase E storage buffer at 4 ºC overnight and concentrated 
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using Amicon Ultra Ultracel-30K centrifugal filter devices. RhlB and enolase proteins 
were purified following the same procedure as Pnpase. All proteins used in this study 
were more than 95% pure as determined by Gelcode bluestained (Thermo, MA) SDS 
PAGE. The final protein concentrations were determined by Nanodrop® ND-1000A 
(Thermo Scientific, DE) at their corresponding molecular weights and extinction 
coefficients (protein calculator v3.3) 
The RraA and RraB proteins were purified using similar approaches except that the host 
strain carrying the pTrc99A-RraA/RraB constructs was AC27 (MC1061, rne(ams), 
rne131 i.e.  the C-terminal rne (585-1061) truncation) instead of BL21(DE3). After 
elution, RraA and RraB proteins were concentrated and buffer exchanged into low salt 
buffer (20mM Tris-HCl, pH7.5) using Amicon Ultra Ultracel-10K centrifugal filter 
devices. (Millipore, MA).  The concentrated protein solutions were then applied to a 
MonoQ HR5/5 anion exchange column (GE healthcare, UK). Proteins were eluted as 1 
ml fractions using 35ml of 20mM Tris-HCl (pH7.5) and a salt gradient ranging from 0 to 
1 M NaCl. The eluant was then dialyzed into RNase E storage buffer at 4 ºC overnight 
and concentrated again. The use of AC27 RNase E truncated strain coupled with the 
purification steps lowered nucleic acid and RNase contamination significantly to levels 
that did not influence subsequent kinetic analyses.  
IMMUNOPRECIPITATION AND WESTERN BLOTTING 
2 µM of C-terminal truncated RNase E (1-845 residues) with a Histidine tag, and 
different amounts of enolase or RhlB were incubated with 10ul of Ni-NTA agarose  
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beads (Qiagen, CA) in binding buffer (150 mM NaCl, 10 mM imidazole, 10% glycerol, 
50 mM Tris-HCl, pH 8.0)  at 4 ºC for 1.5 hour with shaking (200 rpm). For co-
precipitation of Pnpase in the presence of RhlB, 18µM of RNase E, 0-3 µM of RhlB and 
1-4.5 µM of Pnpase were used in the binding step. The protein-bead mixture was 
centrifuged at 1500 rpm for 2 mins and washed thrice with 300 µl of washing buffer 
(150mM NaCl, 10mM imidazole, 10% glycerol, 1% NP-40, 50mM Tris-HCl, pH 8.0). 
After the final wash, Ni-NTA beads were collected and re suspended in 2x SDS PAGE 
loading buffer, proteins were resolved on an 8% SDS-PAGE. RNase E bands were 
detected by Western blotting with anti-Histidine-HRP conjugated antibody (Sigma, MO) 
diluted to a ratio of 1:2000. RhlB, Enolase and Pnpase were detected by Western blotting 
with anti-FLAG antibody (ECS HRP conjugated antibody, BETHYL, TX) diluted to a 
ratio of 1:10,000. 
Results 
PURIFICATION OF DEGRADOSOME COMPONENTS UNDER DENATURING CONDITION 
The catalytic core (N-terminal 498 aa) of RNase E shares sequence homology to RNase 
G. This truncated RNase E has been the subject of numerous biochemical analyses using 
different RNA substrates. However, the lack of the C-terminus in this protein fragment 
makes it impossible to study the effect of other degradosome components on the 
processing of substrate RNAs by RNase E.  
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To date, almost all biochemical studies of RNase E function have been done with C-
terminal truncated versions owing to the technical difficulties involved in the production 
and purification of full length RNase E. There are three major causes for these 
difficulties: First, as mentioned above, RNase E activity is tightly controlled in vivo. Over 
expression of RNase E and the subsequent increase in its activity is very detrimental to 
cell growth. Second, full length RNase E is very unstable and susceptible to proteolytic 
degradation during the purification process. Finally, RNase E is a membrane associated 
protein attached to the inner membrane and this complicates purification. To overcome 
these problems, our lab constructed vectors for the expression of various truncated 
versions of RNase E protein containing the first 499aa, 752aa, or 845aa as well as the 
1045aa near full length enzyme (lacking the 16 C-terminal aa). We found that the 499aa 
and 752aa truncated versions were very easy to purify under native conditions. Longer 
proteins expressed from a T7 promoter however formed insoluble inclusion bodies.   
Therefore we sought to purify these proteins by refolding from denaturing conditions.   
Briefly inclusion bodies were dissolved in 7M urea, the detergent triton X-100 was added 
(0.1%) to increase solubility and the denatured protein was purified by Ni 
chromatography. The protein was then refolded by gradually dialyzed against the RNase 
E storage buffer as described in Methods. Using this procedure we obtained a of the 
RNase E 845aa fragment and of the full length RNase E of about 15 mg/liter culture and 
5 mg/liter culture, respectively with a purity >90% as determined by SDS-PAGE (from 
an A600 of 2.0 culture) (Figure 3.1). It should be noted that the full length RNase E 
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protein migrates at about 200 kDa on a SDS PAGE despite possessing a molecular 
weight is about 120kD.  This abnormal migration property is due to the Proline rich tails 
at the C-terminals of RNase E. (Cormack, Genereaux, & Mackie, 1993). In contrast to the 
full length protein the 845 aa truncated version of RNase E protein we generated does not 
show abnormal migration on SDS-PAGE. 
For the other three major components of the RNA degradosome, we took advantage of 
previously constructed strain collection of E.coli strains encoding proteins tagged with a 
C-terminal SPA (sequential peptide affinity) tag, which contains three modified FLAG 
sequences and a calmodulin binding peptide (CBP) separated by a TEV protease cleavage 
site. Affinity chromatography using immobilized anti-FLAG antibodies was used to 
purify RhlB, Enolase, and Pnpase (Butland et al., 2005). The SPA tag enables us to detect 
these proteins using anti-flag antibody and to monitor complex formation in vitro as 
discussed below. Because of the high specificity and affinity of antigen binding, we were 
able to get very pure protein after one step affinity purification. The yield of RhlB and 
enolase using this purification system was about 15 mg/liter. The yield of Pnpase using 
this purification was about 20mg/ liter. 
PROTEIN INTERACTION DETECTED BY IN VITRO IMMUNOPRECIPITATION 
It is well established that those four proteins: RNase E, RhlB, Pnpase and Enolase form 
the degradosome complex in vivo. Pull-down assays using truncated RNase E mutants 
have mapped the different binding sites on the C-terminal of RNase E(Callaghan et al., 
2004; Gao et al., 2006). We verified that purified proteins can interact in vitro and form 
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degradosome complexes by co-precipitation (pull down) experiments using Ni-NTA 
beads. Purified-N terminal 6xHistidine tagged RNase E 1-845aa protein were absorbed to 
Ni-NTA beads and incubated with RhlB or, enolase respectively. Following stringent 
washes to remove non-specifically bound protein to the beads, the resin was collected by 
centrifugation, resuspended in SDS-loading buffer and heat denatured. Samples were 
subjected to gel electrophoresis and immune blotting with anti-FLAG antibodies.  An 
un-related 6xHistindine tagged IgG protein of the similar molecular weight as RNase E 
1-845aa was used as a negative control (Data not shown). 
The RNase E 1-845aa fragment which contains the RhlB and enolase binding sites were 
able to pull down C-terminal tagged RhlB and enolase respectively as expected, (Figure 
3.1B top two panels).  In the enolase experiment, we demonstrated saturation of Enolase 
binding: using 2 µM RNase E as bait, the amount of pulled down enolase is similar in 
reactions where the concentration of enolase was increased 2-fold from 7.5 to 15 µM. 
Previous in vivo pull-down assays demonstrated a binding ratio of enolase to RNase E 
between 1 and 2. Our data here is consistent with this estimate. It should be noted that the 
structure of enolase co-crystallized with RNase E binding peptide (Chandran & Luisi, 
2006) C-terminal SPA tag should not interfere with the protein interaction between 
enolase and RNase E. It has been reported that the binding affinity between RNaseE and 
RhlB are within the 10 nM range.  The in vitro pull down experiments using the 845 aa 
truncated RNase E and C-terminal SPA tagged RhlB in Figure 3.1B confirm this 
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interaction. Moreover, our data is consistent with a stoichiometric ratio between RhlB 
and RNase E binding which is 1:1 (monomer ratio). 
RHLB ENHANCES PNPASE BINDING IN DEGRADOSOME 
RhlB and Pnpase can form a strong complex in vivo. For several years, the β subunit of 
Pnpase was mistaken for enolase. It was not until 2005 that Lin Pei Hsun et al. rectified 
this assumption and proved that this degradosome subunit was actually RhlB (Lin & Lin-
Chao, 2005) and that the two enzymes from a α3β2 complex. We used size exclusion 
chromatography to confirm the formation of the complex of α3β2 complex between RhlB 
and Pnpase. We also determined that Pnpase “piggy backs” onto RhlB to form a ternary 
Rnase E:RhlB:Pnpase complex with truncated RNase E lacking the Pnpase binding site. 
(1021-1061aa).  As shown in Figure 3.1B lower panel, in the presence of RhlB, Pnpase 
can be pulled down by the 845 aa RNase E fragment. RhlB is required to promote the 
Pnpase pull down. In Fig 3.1 B RhlB and Pnpase can be differentiated based on their 
molecular weights difference.  No such observe such “bridging” of “piggy back” effect 
was observed with Enolase.  The amount of Pnpase that can be pulled down is dependent 






Figure 3.1 Purification results of recombinant degradosome proteins and in vitro immune 
precipitations of degradasome components by RNase E.  
(A). N-terminal Histidine-tagged RNase E (1-1045aa.), RraA and RraB were purified as 
described in Methods and shown here on SDS-PAGE is an example of purified protein 
fractions after overnight dialysis (refolding) in RNase E storage buffer. C-terminal SPA 
tagged enolase, RhlB and Pnpase proteins were purified using anti-Flag agarose (Sigma, 
MI) affinity purification and dialyzed overnight in RNase E storage buffer. (B). 
Degradosome proteins co-precipitated using purified 845 aa RNase E fragment and Ni-
NTA beads were analyzed by a western blot. Indicated amounts of protein were used in 
each co-precipitation reaction. The degradosome components proteins were C-terminal 
SPA tagged and detected by an anti-FLAG antibody as described previously. This in vitro 
experiment demonstrated the complex formation; moreover, it shows that the RNase E 
fragment exclude Pnpase binding site can pull down Pnpase via RhlB.  
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PURIFICATION OF RRAA AND RRAB TO REDUCE NUCLEASE CONTAMINATION 
The isoelectric point (pI) of RraA and RraB proteins are 4.19 and 3.78 respectively, and 
therefore amenable to anion exchange chromatography purification. However, to 
investigate the effect of RraA and RraB on RNA degradation in vitro, it is critical to 
generate high quality protein devoid of any ribonuclease contamination. We found that 
prior to anion exchange chromatography nuclease treatment essentially eliminates 
contamination by negatively charged nucleic acids. Additionally we expressed these 
small proteins under a Trc promoter in pTrc99A vector in a strain lacking the C-terminal 
of RNase E to eliminate co-purification of RNase E. Finally the protein was purified by 
first denaturing with urea followed by IMAC chromatography under denaturing 
conditions and refolding prior to ion exchange chromatography.  Incubation of the 
purified proteins with both short and long RNA substrates did not show any detectable 
RNase contamination under our experimental conditions. 
Discussion 
The major components of the E. coli degradosome are RNase E, RhlB, enolase and 
Pnpase. The structural and functional implications of the molecular interaction between 
these components have been the subjects of years of investigation. To date, the 
dissections of the C-terminal portion of RNase E that recruit the other degradosome 
components has been mapped (Callaghan et al., 2004; Gao et al., 2006). Likewise, the 
sites of interaction on RhlB, enolase and Pnpase have been illustrated along with the 
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crystal structures solved for these components bound to its corresponding RNase E 
peptides. ITC and SPR analysis has been applied to determine the dissociation constants 
for the protein interactions (Chandran et al., 2007; Chandran & Luisi, 2006; 
Nurmohamed, Vaidialingam, Callaghan, & Luisi, 2009). The RNase E peptide 
corresponding to RhlB binding site has been shown to activate RhlB by facilitating role 
RNA binding (Worrall, Howe, McKay, Robinson, & Luisi, 2008). The knowledge 
surrounding other functional interactions between degradosome is rudimentary at best. 
The overall significance of the 500-700 KDa degradosome complexes has been 
established three decades ago. However, little is known about the role of the individual 
components in RNA degradation, particularly with regards to the decay of different 
transcripts. 
In order to biochemically analyze the complex by altering its composition, it is necessary 
to reconstitute the complex in vitro which requires the purification of individual 
degradosome components in substantial amounts (It is worth noting that this is also 
related to the sensitivity of the kinetic assay applied and its signal to noise ratio).  
However the full length RNase E protein which is the key component in organizing the 
RNA degradosome is a membrane-anchored protein that is prone to proteolytic 
degradation during purification. With the help of advanced protein purification 
techniques developed in our lab we have successfully purified milligram amounts of 
truncated versions of RNase E lacking only 16 aa from the C-terminal. The direct 
interaction between the truncated RNase E and purified RhlB or Enolase was illustrated 
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using in vitro immunoprecipitation.  Intriguingly, the truncated RNase E lacking the 
Pnpase binding site (Segment D) pulls down Pnpase when RhlB is present. In fact the 
dissociated between Segment D of RNase E protein and Pnpase is in the µM range, which 
is not a strong interaction (Nurmohamed, Vaidialingam, Callaghan, & Luisi, 2009b). The 
“bridging” effect of RhlB could enhance the interaction between Pnpase and RNase E in 
vivo. Under physiological conditions, RhlB, and common substrate of RNase E and 
Pnpase, for instance, a long string of RNA could enhance such interactions drastically. 
Building the RNA degradosome complex in vitro not only enables us to understand its 
function, but also makes it possible to investigate the role of RraA and RraB, which have 
been discussed in detail in Chapter 2. These two small proteins modulate the 
degradosome function in vivo, by specifically reducing the amount of RhlB bound upon 
over expression. Moreover, over expressed RraA and RraB generate distinct transcript 
profiles, suggesting that they utilize different strategies in modulating the degradosome 
complex and this effect to some degree is transcript-specific (Gao et al., 2006). To better 
undertand the mechanism of selective inhibition by RraA and RraB in vitro, we needed to 
produce high quality proteins that are devoid of ribonuclease and other contaminants for 
kinetic analyses. By expressing the protein in an RNase E truncation mutant strain, 
introducing denaturing purification step and following up with an ion exchange 
chromatography separation, such proteins could be generated at high purity and yield. In 
the next chapter I will describe the use of this in vitro reconstituted degradosome 
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complex in the presence of RraA or RraB to examine the effects of RraA/B on the in 













CHAPTER 4 INHIBITION OF RRAA/RRAB ON RNASE E AND 
DEGRADOSOME 
Introduction 
In chapter 3 I described the reconstitution of RNA degradosome by individually purified 
degradosome components. In this manner, we can adjust the ratio of different 
components or add in the two protein inhibitors RraA and RraB in biochemical assays.  
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Because the Chapter 1 of this dissertation has summarized the structure, function and 
regulation of RNase E protein, the biochemical properties of RNass E which are of 
relevance to kinetic study, will be detailed in this introduction.  
RNase E (E C 3.1.26.12) was first identified as 70KDa protein which can process 9S 
RNA in a stepwise manner.  The 70KDa protein was later shown to be partially 
degraded RNase E since the full length protein is very unstable during purification (Mudd 
& Higgins, 1993). The cleavage of various RNA substrates of RNase E has been studied 
in vivo and in vitro. In vivo studies have relied on the use various RNase E mutants.  
Among these mutants, the best studied are rne-1 and rne3071; the latter has amino acid 
substitutions in the S1 RNA binding domain of the N terminal Half of RNase E. These 
mutants confer temperature sensitive growth. Various C-terminal truncation mutants of 
RNase E have also been constructed, (e.g. rne-131(Δ477), rneΔ610) or isolated by 
exploiting the temperature sensitivity caused by defective for tRNA maturation. Current 
evidence supports the notion that the essentiality of RNase E is because of its role on 
tRNA processing (Ow & Kushner, 2002; Li & Deutscher, 2002; Söderbom, Svärd, & 
Kirsebom, 2005).  
In vitro studies of the cleavage of, several well- defined short RNA substrates, such as 
BR10 and BR13(Redko et al., 2003) which are derived from the p23 RNA, long RNA 
substrates, such as RNA1 and 9S RNA, and various derivatives of 40 nucleotides long 
poly A RNAs by the N-terminal catalytic domain of RNase E have been performed. The 
specificity of RNase E has been studied by examining the effects of nucleotide 
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substitutions in the established RNA substrates listed above. A partial recognition motif 
for RNase E has been proposed from the cleavage of 27 nucleotides long RNA substrates: 
(G,A)(C,A)N(G)(GUA)_(A,U)(C,U)N(C,A)(C,A) (underline indicates RNase E cleave 
site) ((Kaberdin, 2003). 
RNase E activity requires both monovalent ions e.g. Na+, K+, NH4
+ and bivalent ions e.g. 
Mg2+, Mn2+. The optimum reaction pH is 7.6 to 8.0. The optimum reaction temperature is 
around 30 °C. RNase E can be irreversibly heat inactivated at 50°C (Misra & Apirion, 
1979). 
It has been reported that RNase E N terminal domain, as well as its bacteria homolog 
RNase G protein prefers a 5′ mono-phosphated than 5′ tri-phosphated RNA substrate. 
(Mackie, 1998; Jiang & Belasco, 2004) In this model, the naturally occurring 5′ tri-
phosphated RNA transcript is a slow substrate for RNase E, however once it′s cleaved, a 
5′ mono-phosphate is generated, and the rest of the transcript is degraded quickly, which 
is consistent with the “all or none” phenomenon in bacteria mRNA decay. Moreover, a 5′ 
pyrophosphatase activity has been discovered from E.coli recently, RNA 
pyrophosphohydrolase (RppH) removes the protective di-phosphate from the 5′ end of 
mRNA (Deana, Celesnik, & Belasco, 2008). However, the fact that rppH mutants 
selectively stabilize a set of transcripts suggests that 5′ end independent pathways exist in 
mRNA decay. Moreover, several mRNAs have been shown to be rapidly cleaved by 
RNase E independent of the phosphorylation status at their  5′ ends (Kime, Jourdan, 
Stead, Hidalgo-Sastre, & McDowall, 2009; Jourdan, Kime, & McDowall, 2010). Given 
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that most of the 5′ end-dependent substrates were either short single stranded RNA or 
long substrates that are being processed by RNase E near their 5′ extremities, it is 
tempting to hypothesize that the significance of the 5′ end in RNase E cleavage is 
dependent on whether the enzyme has “direct entry′′ into a single stranded site. This is 
supported by comparison of the structure of RNase E alone comparison to its RNA-
bound form (Koslover et al., 2008b). Additionally the physiological significance of a 5′ 
mono-phosphate RNA substrate is not clear. An earlier in vitro study suggested that the 
consequence of a mono-phosphate over a tri-phosphate substrate is a faster catalytic rate, 
i.e. higher kcat value (Jiang & Belasco, 2004).  However a recent in vivo study suggested 
that the mono-phosphate binds to RNase E NTH with a higher affinity, i.e. a lower Km 
value (Jourdan & McDowall, 2008). The protein structure data is in favor of the later 
notion (Koslover et al., 2008b).   
Structural data and studies of the RNase E homologues indicate that the protein forms a 
tetramer (Callaghan et al., 2003; Zeller et al., 2007;  Koslover et al., 2008b;  Callaghan 
et al., 2005b) Whether this oligomerization affects its catalytic activity awaits more 
experimental elucidation. Truncation of the RNase E N-terminal half containing only the 
1-395 residues which does not contain the domain interaction sites, thus assumed to be a 
monomer, remains kinetically active towards the BR30M RNA substrate, and is able to 
complement the rne null mutant (Caruthers, Feng, McKay, & Cohen, 2006). An earlier 
study using MBP-tagged RNase E NTH in which the MBP tag can prevent the tetramer 
formation, found that monomer RNase E cannot discriminate between 5′phosphate RNA 
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or 5′hydroxyl RNA, whereas the multi-metric state of RNase E cleaves the 5′ mono-
phosphate substrate at least 18 times faster than the hydroxyl substrate. This indicates the 
requirement of tetramer formation in recognizing the 5′ mono-phosphate RNAs.(Jiang & 
Belasco, 2004) 
Pnpase (EC 2.7.7.8) was first discovered in 1955 by Grunberg-Manago and Ochoa while 
studying phosphorylation in Azotobacter vinelandii. Initially the enzyme was considered 
as an RNA polymerase. Later it became clear that its main function in the cell is the 
reverse reaction, namely, phosphorylysis of RNA. Pnpase is an evolutionarily conserved 
enzyme found in all three kingdoms. In E.coli it is implicated in mRNA degradation and 
ribosome biogenesis. We have discussed the structure, regulation of pnp gene, and its 
interaction with RNase E and RhlB in detail in Chapter 1: Pnpase from E.coli consists of 
five domains, two RNase PH domains sited at the N terminals serve as catalytic core, and 
two RNA binding domains, KH and S1 located near the C terminal, with an all α helical 
domain linked in between. Pnpase catalyzes two different reactions under specific 
conditions: exchange of the β-phosphate group of nucleoside diphosphate and free 
orthophosphate; polymerization of single stranded RNA from nucleoside diphosphate and 
the reverse 3´ to 5´ processive phosphorylysis of RNA, releasing nucleoside diphosphate. 
As aforementioned, the processive phosphorylysis reaction is inhibited by low inorganic 
phosphate concentration or high ATP concentrations (Del Favero et al., 2008). Pnpase 
requires a single-strand region near the 3′ of RNA for phosphorylytic degradation of 
RNA. A minimal of 7-10 nucleotides 3´ overhang enables specific substrate binding to 
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Pnpase.  In vivo, this requirement is met by two means: addition of poly (A) tails or by 
RhlB unwinding. Pnpase can exist as α3β2 complex where the β subunit is RhlB. This 
interaction between Pnpase and RhlB is independent of RNase E. 
The optimal pH for Pnpase phosphorylysis reaction is between 8 and 9.5. The preferred 
divalent mental for Pnpase is Mg2+ or Mn2+. For oligonucleotides (between 2-10 
nucleotides) the Km for phosphate is 0.7mM, which is independent of substrate sequence. 
The Km for oligonucleotides ranges from 0.13mM (4nt) to 0.05mM (6nt and higher).  
The trend is that within a series of oligonucleotides containing similar sequences, the Km 
decreases as the chain length increases, eventually reaches a plateau at a concentration of 
50µM for the E.coli Pnpase. In the case of polynucleotides longer than 20 nucleotides, the 
Km keeps decreasing with length and reaches the nM range for substrates longer than 100 
nucleotides (Godefroy-Colburn, T.; Grunenberg-Manago, 1972). The change in Km 
values according to substrate length indicates multiple RNA interaction sites on Pnpase. 
Indeed, the phosphorylysis of polynucleotide is “processive”, i.e. Pnpase binds to the 
substrate, degrades the entire substrate to completion prior to binding and degradation of 
another polynucleotide. It is worth mentioning that the phosphorylysis of short 
oligonucleotides by Pnpase occurs in a non-processive manner.  Moreover, it has been  
hypothesized RNAs trapped in certain conformations are resistant to Pnpase degradation, 




Pnpase has been identified as a cold shock protein. Pnpase deletion mutant cannot grow 
at lower than normal temperatures. The knowledge about Pnpase function in the cold is 
still rudimentary. Certain mutations in the KH and S1 domains confer cold-sensitivity.  
A truncated form of Pnpase lacking the S1 domain was able to complement the cold 
sensitivity of a pnp deficient nonsense mutant. This domain located in the C-terminal 
region of Pnpase is believed to contribute to its processivity. Mutations in this region, 
although have limited effect on phosphorylysis activity, significantly affect substrate 
binding and thereby increase the Km (Briani et al., 2007). 
Compared with RNase E and Pnpase, the role of RhlB is not well understood at the 
molecular level. RhlB belongs to a protein family named DEAD-box RNA helicase.  
Besides the structure organization and some functional properties discussed in Chapter 1, 
here I focus on its specificity, kinetic properties and mutagenesis of RhlB. 
To date, there are five DEAD-box RNA helicases known in E.coli: DbpA, CsdA, RhlE, 
SrmB and RhlB. Only one of these five enzymes, DbpA, displays sequence-specific 
substrate binding, and is involved in 23S rRNA processing. The other four DEAD-box 
RNA helicases may require interaction with other proteins for sequence recognition. Of 
particular interest to this study, RhlB is known to interact with the C terminal fragment of 
RNase E and Pnpase separately.  
DbpA unwinding requires single-strand extensions at the 3´ extremity of an RNA duplex. 
Such single-strandness requirement is not rigid in the other four helicases involved in 
RNA processing. This is probably also due to the availability of protein partners which 
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present them the substrate. CsdA and SrmB can utilize either 3´ or 5´ extensions, whereas 
RhlE can unwind duplexes with blunt ends (Iost & Dreyfus, 2006). RhlB, in contrast to 
the other four DEAD-box helicases, do not process unwinding activity or ATPase activity 
on its own in vitro. ATP hydrolysis and RNA unwinding is detected when RhlB is 
activated by a peptide fragment from the C-terminal of RNase E (628-843aa).Because 
this region of RNase E is implicated in RNA binding, the observed 5′ single-strandness 
requirement in the RNA unwinding assays by RhlB/RNE (628-843aa) complex (Iost & 
Dreyfus, 2006) could be a consequence of the RNase E fragment it binds to.  
RhlB, like most DEAD-box RNA helicases involved in RNA processing, has very poor 
processivity. Therefore in vitro assays for RhlB and other DEAD box enzymes 
unwinding activity are performed either by using an excess amount of enzyme relative to 
substrate, or in a coupled reaction whereby the unwound RNA is immediately degraded 
by other ribonucleases. Recently, Cartier et al. developed a continuous helicase assay 
using a FRET RNA duplex in the presence of large excess of unlabeled complementary 
RNA oligos (Cartier, Lorieux, Allemand, Dreyfus, & Bizebard, 2010). In this assay it is 
assumed that the presence of excess RNA oligos do not affect substrate binding to the 
helicase during the measured reaction time. However this method is still unable to derive 
Km values for the RNA substrate. Using this assay Km values for ATP hydrolysis was 
calculated to be within the milimolar range for RhlE and less than 100µM for SmrB. In 
agreement with the poor processivity of the DEAD box helicases, the unwinding rate 
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constants decrease drastically when the length of the duplex increases from 9 base pairs 
to 11 base pairs for both SmrB and RhlE.  
CsdA is associated with degradosome after cold shock or when RraB, the RNase E 
inhibitor is over expressed. It′s worth mentioning that, CsdA binds at a different site on 
RNase E than RhlB i.e. their binding is not mutually exclusive. Although three of the five 
DEAD-box RNA helicases have been implicated in cold adaption, a mutant devoid of 
RhlB does not show such a phenotype. 
There are several RhlB mutants that have been generated by site direct mutagenesis based 
on rational design.  The active site mutant RhlB H320D loses ATPase activity in the 
presence of RNase E fragment (696-762aa), even though it still binds to the RNase E 
fragment avidly and forms a proper structured protein complex. F10A is a mutation in the 
RNA binding region of RhlB. This mutant was shown to form a complex with RNase E 
(696-762) and showed significant ATPase activity without RNA, but surprisingly little 
activity when RNA was present. Another mutant, F10M, when bind to an RNase E 
fragment, also had little activity when RNA was present, but its activity without RNA 
was comparable to wild type RhlB/RNase E fragment complex when RNA was present. 
In other words, the F10M mutation mimics the situation where RNA activates the 
ATPase activity in wild type enzyme, however when RNA is present, such an 




The existence of enolase in the RNA degradosome is mysterious. As a glycolytic 
enzyme, enolase has been the subject of systematic studies of its structure, function and 
kinetic properties (Reed, Poyner, Larsen, Wedekind, & Rayment, 1996). However, how 
enolase affects mRNA turnover by RNA degradosome is unknown.  
Using the degradosome complex reconstituted in vitro as described in Chapter 3, in this 
chapter, I tested the consequences of RraA and RraB binding on the kinetics of RNA 
degradation: First, the effects of RraA and RraB on RNase E hydrolysis of a 14 
nucleotide synthetic RNA substrate were determined. Second, the effect of RraA and 
RraB on the cleavage of two different polynucleotides RNA substrates with different 
tertiary structures was also investigated. A moderate degree of mixed inhibition was 
observed for both RraA and RraB on the hydrolysis of the 14 nucleotide synthetic RNA 
substrate. By comparison, the processing of a long RNA namely the dsbC mRNA by 
RNA degradosome is severely inhibited by RraA or RraB. 
Materials and Methods 
RNASE E ACTIVITY ASSAYS USING FRET RNA SUBSTRATES 
The P-BR14-FD fluorogenic RNA substrate was synthesized and HPLC-purified by 
TriLink (San Diego, CA). The kinetic assays were performed in reaction buffer (25mM 
bis-Tris propane (pH 8.0), 100mM NaCl, 15mM MgCl2 and 1mM DTT). No background 
RNase activity (i.e. increase in fluorescence signal) was detected using this buffer. The 
concentrations of proteins in each reaction were RNase E (tetramer) 0.25µM, BSA or 
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RraA/B (monomer) 2.5µM. The proteins were incubated on ice for 10 minutes first, then 
warmed to the reaction temperature prior to use. The FRET substrate (final concentration 
varied from 2.5 to 12.5µM) was added, and the reaction was carried out at 25ºC on  96 
well plates, and the change of fluorescence signal was measured on a Synergy HT 
fluorescent plate reader (BioTek, VT) with a 485/20 excitation filter and a 516/20 
emission filter. The initial rate of each reaction was determined as the slope from the 
linear kinetics under different substrate concentrations. The initial rates and derived Km 
and Vmax were calculated using Kaleidagraph v3.6 (Synergy, PA). 
DEGRADOSOME ACTIVITY ASSAY 
To examine the effects of RraA/RraB on the activity of RNase E-RhlB complex, RNA1 
and dsbC was used as substrate, and the loss of the full length RNA band were monitored 
by gel electrophoresis. Reactions were carried out at 37ºC in reaction buffer (1mM ATP, 
1mM DTT, 1mM MgCl2, 25mM Tris-HCl pH8.0 in 1x PBS).  The buffer was made by 
diluting RNase-Free buffer sets purchased from Ambion. RNase-Free PCR plates were 
used to perform the assay on Applied Biosystem 2720 Thermal Cycler. RraA/B proteins 
were incubated with degradosome proteins on ice for 30mins prior to the reaction. RNA 
substrates were diluted in reaction buffer and refolded by incubating at 70ºC for 10mins 
first then the temperature was gradually decreased to 30ºC over 40mins. The refolded 
RNA and incubated proteins were then combined together to start the reaction at 37ºC. At 
each time point, 5µl of properly diluted proteinase K (NEB) was added to the tube to stop 
the reaction. The amount of proteinase K added was adjusted to the amount of protein in 
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the reaction tube. After 30 minutes of digestion by proteinase K at 37ºC, the enzyme was 
inactivated by heating at 75 ºC for 15 mins. 10ul of the 30ul reaction mixture were mixed 
with 2x gel loading dye and the samples were analyzed on 10% Criterion TBE-Urea Gel 
(BioRad, CA). After electrophoresis, gels were stained with SYBR Gold stain 
(Invitrogen, CA) and visualized using Typhoon 9400 scanner. The band intensity was 
quantified by Image Quant. 
IN VITRO TRANSCRIPTION OF RNA SUBSTRATES 
DsbC mRNA truncation template was PCR amplified from plasmid pET28a-DsbC using 
primers covering the T7 promoter region to the 250th nucleotide of the dsbC ORF. The 
RNA1 template was difficult to PCR amplify due to its complicated secondary structures, 
we used a restriction digested fragment from a plasmid (pIDTSMART-T7RNA1) 
containing the T7 RNA polymerase promoter site followed by the RNA1 sequences. The 
plasmid was purified by Maxi prep (Qiagen, CA), digested with EcoR1 and gel-purified 
to generate linear dsDNA template for in vitro transcription using Megashortscript™ Kit 
(Ambion, TX).  Transcripts were purified with MEGAclear Kit (Ambion, TX), RNA 
was properly diluted and quantified by Nanodrop® ND-1000A, following the equation C 
(µg/mL) ≈33 x A260.  
QUANTITATIVE REAL-TIME RT-PCR 
RNA was reverse transcribed into cDNA using a gene-specific primer (5′-AAC AAA 
AAA ACC ACC GC-3′, complementary to 17 bases of RNA1 at the 3′ end) and 
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SuperScript III Reverse Transcriptase (Invitrogen, CA) according to the manufacturer′s 
instructions. For detection and quantification of the uncleaved RNA1, the ABI PRISM 
7900HT Sequence Detection System was used. Real-time PCR reactions were performed 
with goTaq® qPCR master mix (Promega, WI) according to manufacturer′s protocol. The 
specificity of the reaction products was confirmed by dissociation curve analysis. Each 
sample was tested in triplicate, and the change in RNA1 levels was calculated using the 
ΔΔCt method and normalized by a reference DNA. Primer pairs for Real time PCR were 
designed based on SciTools on the idtdna website. 
QUANTITATIVE ANALYSIS OF INHIBITION PERCENTAGE 
Reaction rates in the presence or absence of various amounts of inhibitors, as measured 
by either fluorescence assays or the real time PCR was plotted as relative activity 
(percentage activity) over the concentration of inhibitor. The data were plotted and fitted 
to the equation shown below using the non-linear regression of Kaleidagraph: 
%  	100  %  
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MICHAELIS-MENTEN PARAMETERS FOR THE RNASE E HYDROLYSIS OF FRET 
OLIGONUCLEOTIDES 
A fluorescence resonance energy transfer (FRET) modified 14mer RNA substrate 
originally described by Jiang (Jiang & Belasco, 2004) was used in this study to derive the 
Michealis-Menten parameters for the hydrolysis of short RNAs by truncated RNase E 
lacking the C-terminal 16 amino acids. This FRET fluorogenic RNA substrate, P-BR14-
FD, resembles the 5′ terminal of pBR322 RNA1 which contains a single major RNase E 
cleavage site. The substrate RNA is designed in a way that there is a fluorescein tag 
upstream of the expected RNase E cleavage site and a fluorescence-quenching dancyl tag 
downstream of the cleavage site.  Cleavage by RNase E results in a marked increase in 
fluorescence. Alternatively, cleavage can be determined by gel electrophoresis based on 
the different sizes of substrate and product.  
Although the crystal structure demonstrated that the N terminal catalytic domain of 
RNase E can accommodate a 14 nucleotide RNA, little is known about the effects of the 
RNA binding site which is located at the central region of RNase E (and is not present in 
the N-terminal catalytic fragment used for earlier studies) to its catalytic activity.  To this 
end, we used the RNase E fragment (RNase E1045) lacking only 16 amino acids at the 
very end of C-terminal for kinetic assay, and compared the kinetic parameters with the 
ones obtained previously using NTH RNase E. The Km value obtained with RNase E 
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1045 was 5-fold higher than that for RNase E498 which contains 1-498 residues of 
RNase E (3.2µM versus 0.6µM). This might be due to the presence of the additional 
binding site provided by the central region of RNase E, which competes for the substrate 
with the RNA binding site within the catalytic core. The kcat value obtained with RNase E 
1045 is similar to that for RNase E 498, within 1 min-1 range. (Figure 4.1) 
 
Figure 4.1 Michaelis-Menten parameters for the hydrolysis of FRET substrates. A. The 
FRET substrate used in kinetics assays. The cleavage of RNase E as indicated by the 
arrow separates the fluorophore from the quencher and results in more than 30 fold 
increase in fluorescence signal. (Adopted from Jiang et al. 2004). B. Michaelis-Menten 
parameters derived from steady state analysis using 0-12.5µM FRET RNA substrate 
(shown in C). Quadruplicate data were analyzed using KaleidaGraph. RNase E was 
incubated with RraB (green) RraA (Blue) or BSA (red) on ice for 10 minutes before 
FRET RNA was added and the reaction starts. The initial rate of each reaction was 
determined as the slope from the linear kinetics under different substrate concentrations.  
INHIBITION OF RRAA AND RRAB TO RNASE E HYDROLYSIS OF FRET 
OLIGONUCLEOTIEDS 
RraA and RraB bind to RNase E at the 628-843aa and 694-727aa regions, respectively, 









0.25µM RNase E +2.5µM BSA 3.2±0.4 0.99±0.03 0.31±0.04 
0.25µM RNase E +2.5µM RraA 4.4±0.4 0.87±0.03 0.20±0.02 
0.25µM RNase E +2.5µM RraB 5.6±0.8 0.85±0.05 0.15±0.02 
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would expect that the mode of action of these inhibitors would fit neither competitive 
inhibition nor noncompetitive inhibition. Indeed, our data suggest that RraA and RraB 
both have only moderate effects on Km and kcat of RNase E in the FRET substrate 
hydrolysis and display a mixed inhibition pattern (Figure 4.1). Interestingly, the 
inhibition by RraB is more severe than that by RraA, as judged by the kcat /Km values. 
However, when plotting the inhibited activity (percentage activity) over inhibitor 
concentration, as shown in Figure 4.2, the maxium amount of inhibition, as calculated by 
an exponential fit, is 60% for RraA versus 44% for RraB under the conditions described. 
 
Figure 4.2 Inhibition by RraA/B of 1µM (monomer) RNase E in the hydrolysis of 5 µM 
FRET RNA substrate.  Exponential base e curve fit was used to plot activity change 
over inhibitor concentration (µM of monomer). 
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DEGRADATION OF LONG RNA TRANSCRIPTS BY THE DEGRADOSOME IN VITRO. 
Very little is known about how RNase E cleaves RNA substrates in presence of other 
components of the RNA degradosome. With our RNase E 1045 fragment, which includes 
not only the N-terminal catalytic half but also the binding sites for RraA/RraB, RhlB and 
enolase, we were able to evaluate the effect of these factors.  
Earlier in vivo microarray studies suggested that mRNA degradation requires the 
coordination between different degradosome components. (Bernstein, Lin, Cohen, & Lin-
Chao, 2004) To test the inhibitory effect of RraA/RraB under such circumstances a 
system was developed to reconstitute a minimal degradosome in vitro and examine the 
effects of RraA/RraB on the complex against different substrates. For these assays I 
adopted a more physiologically relevant RNA substrate, i.e. a truncated dsbC mRNA 
which is 300 nucleotides in length.  
Earlier studies by our lab established that dsbC mRNA processing involves RNase E. In 
vivo, lesions in rne increase the half life of dsbC mRNA from 0.82min to about 2mins. 
(Zhan et al., 2004) Moreover, RraA and RraB were first discovered as inhibitors of 
mRNA degradation based on a genetic search for genes that increase DsbC activity.  
When RraA or RraB is over expressed in the cell, the half-life of dsbC mRNA is three to 
five-fold longer (Gao et al., 2006). Gao et al. used a probe hybridizing to the first 1-266 
nucleotides of the dsbC transcript.(Gao et al., 2006).  Here I used in vitro transcribed 
truncated version of dsbC mRNA including a short region of the lac operator (from the 
plasmid vector it is transcribed from) and the 1-250 nucleotide of dsbC.  
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The degradation of this RNA requires the cooperative action of RNase E and RhlB, 
which is consistent with the Mfold structure prediction indicating that the dsbC mRNA 
forms multiple stem-loop hairpin structures within the first 250 nucleotides. As shown in 
figure 4.3, RNase E alone cannot degrade this transcript. In the presence of RhlB, the 
300nt RNA was degraded within 30mins under the reaction conditions we applied. 
Interestingly, when Pnpase was added into the system, forming an RNase E-RhlB-Pnpase 
partial degradosome, the substrate persisted for up to 75mins. Surprisingly, a reaction 
intermediate of about 200 nucleotides long was observed in reactions containing Pnpase 
but not in its absence, one possible explanation is that this RNA is trapped in a 
conformation that is being protected by Pnpase from further degradation. Intriguingly, 
addition of enolase accelerated the reaction compared to the partial degradosome 




Figure 4.3 Degradation of dsbC mRNA.  The assay was done under the conditions 
described in Materials and Method. The amount of RNA and proteins used in each 
reaction (monomer concentration) 25nM dsbC mRNA, 5nM RNase E, 80nM RhlB, 
30nM Pnpase, and 40nM Enolase.Samples was taken at various time points: 0, 15, 30, 45, 
60 and 75mins. 
 
Compared to dsbC mRNA, RNA1 has a longer half life in vivo (0.82min versus more 
than 3min). The degradation of RNA1 also requires RhlB unwinding activity. The 
involvement of Pnpase in RNA1 degradation requires the addition of a poly A tail, the 
effect of enolase on RNA1 degradation is still under investigation. 
RNase E + + + +
RhlB - + + +
Pnpase - - + +




INHIBITION THE RNA DEGRADOSOME BY RRAA AND RRAB  
It was reported that the Ki value for the inhibition of the BR13 substrate by RraA is 
2.5µM.  Under similar conditions the Ki value for the pM1 RNA substrate degradation 
by RNase E was reported as 0.5 µM (Lee et al., 2003). In the case of dsbC mRNA, RNase 
E protein alone cannot degrade this 300 nucleotides long transcript on its own efficiently, 
and other degradosome components, especially RhlB are required for the fast degradation 
of RNA. We explored the inhibitory effect of RraA or RraB on the inibhition of 
degradosome activity. We showed in Figure 4.4 that 0.12 µM of either inhibitor 
successfully inhibited the reaction to more than 50%. Due to the limitations of the 
dynamic range in gel electrophoresis, we could not perform systematic kinetic assays to 
calculate Ki values.  This data demonstrated that nanomoler concentrations of RraA or 
RraB, which is comparable to substrate concentration applied in the assay, can cause 
drastic stabilization of transcripts susceptible to degradation by the degradosome 
complex. 
 
Figure 4.4. Inhibiton of RraA and RraB on the degradation of dsbC mRNA. Reaction 
conditions were same as Figure 4.3, except that 120nM of RraA or RraB were added in 
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the reaction as indicated in the panels on top. Reaction time: 0, 15, 30, 45, 60, and 
75mins. 
 
RNA1 is a small regulatory RNA used by ColE1 origin plasmid to control its copy 
number. It affects the plasmid copy number by binding and thus inhibiting the maturation 
of RNAII which serves as the DNA replication primer once it is processed. RNA1 is a 
short RNA transcript slightly longer than 100 nucleotides in length which folds into a 
cloverleaf structure. The central loop of this cloverleaf is important for base-pairing with 
its target RNAII. It was also suggested that this interaction does not involve a large 
number of bases (Lacatena & Cesareni, 1981).  The sequence specific RNA1-RNAII 
interaction is enhanced by a 63 amino acids small protein encoded by the plasmid, Rom 
(RNA one modulator). Rom recognizes either the complex formed by two RNAs and 
stabilizes it or the individual RNAs and induces a stable complex formation. It is 
interesting that Rom stabilized a specific RNA conformation irrespective of its exact 
sequence (Eguchi & Tomizawa, 1991). The structure of the loop-loop complex formed 
between the RNA1 and RNAII complementary loops has been solved. Although the 7 
nucleotides that are involved in this interaction form a perfect Watson-crick base pair, the 
structure of the complex is different from the A form of RNA helices. Instead, the loop-
loop complex bends towards the major groove, thereby narrowing it. This bending feature 
is proposed to be the sequence-independent structure feature that is recognized by the 
Rom protein (Lee & Crothers, 1998). RNase E is involved in degradation of RNA1. The 
degradation of RNA1 by RNase E has been studied in vivo and in vitro (Bouvet & 
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Belasco, 1992; Kaberdin, Chao, & Lin-Chao, 1996). The half life of RNA1 is about 3 
minutes in wild-type E.coli strains. The degradation of RNA1 is triggered by RNase E 
cleavage at a unique site near the 5´ end, and this endonucleolytic cleave is sensitive to 
the 5´-terminal base paring (Bouvet & Belasco, 1992). Besides the initial attack by 
RNase E at the 5´ terminal of RNA1, multiple cleavage sites located in the bubbling 
regions of its stem loops has been identified in vitro (Kaberdin, Chao, & Lin-Chao, 
1996). Using various rne deletion mutants, the degradation pathway of RNA1 has been 
studied in detail. It was shown that the ARRBD region of RNase E is essential for the 
initial endoribonucleolytic cleavage of RNA1, which indicates the involvement of RhlB 
in unwinding the secondary structure of RNA1 (Nishio & Itoh, 2009).  In recent studies  
of RraA and RraB, the copy number of the ColE1 origin plasmid was used as an indicator 
of RNase E activity in vivo (Lee, Yeom, Sim, Ahn, & Lee, 2009; Yeom et al., 2008).  It 
is noteworthy that another RNase E inhibitor, L4, also has stabilizing effect on the RNA1 
transcript in vivo (Singh et al., 2009).    
We showed that RNase E alone poorly process RNA1 in vitro (data not shown) and that 
the reaction is greatly accelerated by addition of RhlB, presumable because of its RNA 
unwinding activity. Our data (Figure 4.5) suggested that under the reaction conditions 
used here (i.e. RNase E-RhlB partial degradosome) RraB inhibits the decay of RNA1 to a 
greater extent relative to RraA. This is consistent with the findings in vivo as mentioned 
above where over expression of RraB causes a greater reduction in ColE1 origin plasimid 
copy number (Yeom et al., 2008). Based on the decrease in band intensity of 105 
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nucleotides long RNA1, which is the product formed after first 5 nucleotides has been 
processed, the gel showed in Figure 4.5 suggested that under the conditions used, RraA 
reduced the reaction rate by 40% whereas RraB reduced the reaction rate by more than 
50%.  
Real time PCR analysis was used to quantify various amount of full length RNA1 
remaining at different time points. The primers used for the Real time PCR were 
designed in a way that only full length RNA1 could be amplified, which means we 
specifically monitored the fast cleavage reaction happening at the first 5 nucleotide site.  
We used Real time PCR to monitor the loss of full length RNA1 because the band 
intensity of this full length RNA could not be quantified at low substrate concentrations. 
The detection limit of Real time PCR method was much lower and suitable for such 
analysis. Our data showed that RraA inhibited the fast cleavage reaction by 
approximately 35%, whereas RraB inhibited the reaction by about 80% as shown in 
Figure 4.6 (exponential fit). A 400 base pair double stranded PCR product unrelated to 
RNA1 was used for both the gel electrophoresis assay and for real time PCR assays as a 




Figure 4.5 Inhibition on the decay of RNA1. A.The secondary structure of RNA1 and 
multiple RNase E cleavage sites on it (Kaberdin, Chao, & Lin-Chao, 1996). B. 
Degradation of RNA1 by RNase E and RhlB partial degradosome and inhibition by RraA 
and RraB. The RNA and proteins used in the reactions were: 24nM RNA1, 5nM RNase 




RNase E + + +
RhlB + + +
RraA - + -





Figure 4.6 Inhibition of RraA/RraB on 5nM RNase E and 80nM RhlB processing of 24 
nM full length RNA1, as measured by Real time PCR. Relative reaction rates were 
derived from the average of triplicates data. An exponential base e curve fit was used to 
plot activity change over a gradient of inhibitor concentration. All protein concentrations 
were demonstrated as monomer concentration. 
 
Discussion 
Although the N-terminal catalytic half of RNase E has been used in numerous kinetic 
studies using various RNA substrates, little is known regarding the role of the central and 
C-terminal region in RNA processing. As the first and preliminary step of investigating 
RraA/RraB inhibition, we purified the 1045 amino acids truncated version of RNase E, 
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and compared its catalytic properties to its N-terminal half portion (1-498 aa). Our data 
indicated that the catalytic activity kcat is comparable for both versions of RNase E 
truncation. However, the Km for the synthetic FRET RNA is increased in RNase E 1045, 
which may due to the competitive binding between two different RNA binding sites, one 
in the catalytic domain and other near the central region. It was recently reported that 
RNase E hydrolysis of short RNA substrates displayed two phase kinetics (a boost at the 
first 10 mins then a slow steady phase that lasted for hours) (Jourdan, Kime, & 
McDowall, 2010). We also observed a similar phenomenon. In our analysis we calculated 
the steady state kinetics parameters for the second, slow phase. The kinetics of the slow 
phase were similar to those published earlier for the N-terminal half of RNase E (Jiang & 
Belasco, 2004). 
The discovery of RraA and RraB revealed a novel regulatory mechanism whereby the 
remodeling of the RNA degradosome affected the half life of mRNA and thus the 
abundance of the respective proteins (Kangseok Lee 2003). In this chapter, we showed 
that RraA and RraB moderately inhibit RNase E hydrolysis of the 14 nucleotide synthetic 
RNA in a mixed inhibition manner. Furthermore, inhibiton was saturated at stoichimetric 
ratios of RraA/RraB, where approximately 50% inhibition is reached. 
Over expression of RraA/RraB alters the composition of RNA degradosome in vivo (Gao 
et al., 2006). To test the effect of the inhibitors on RNA processing by the RNA 
degradosome, RNase E, RhlB, enolase and Pnpase were purified individually and 
allowed to a complex in vitro. The presence of RraA/RraB resulted in significant 
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inhibition of the degradosome in the decay of dsbC mRNA, whereas moderate inhibition 
were found for degradation of RNA1.  
During our analysis of RNA1 degradation, we realized the limitations of gel 
electrophoresis assay especially their low sensitivity. By designing proper primer pairs 
we developed a Real time PCR which provided greatly increased sensitivity. We 
speculate that this method will be very useful in future for two reasons: first its high 
sensitivity and relative high throughput will reduce the amount of effort required for 
conventional RNA assays using gel electrophoresis; Second, by designing the suitable 
primers, various intermediates during RNA decay pathway can be specifically quantified 
simultaneously, making it possible to dissect the fast and slow steps of RNA decay 
pathway. 
How do RraA and RraB inhibit RNA decay? Based on the work presented here, we 
propose that RraA and RraB can reduce the intrinsic activity of RNase E and carry out 
their inhibitory function mostly by interfering with the coordination between different 
RNA degradosome components in vivo. The significant inhibition we observed for the 
cleavage of the dsbC mRNA, relative to the moderate inhibition of the FRET substrate 
hydrolysis supports this hypothesis. Moreover, a recent paper demonstrated that RraA 
affects RNA binding by RhlB-RNase E complex in vitro (Gorna et al., 2010). A 
quantitative way of testing this hypothesis is compare the composition of in vitro 
reconstituted degradosome complex in the presence and absence of RraA/RraB 
inhibitors. Moreover, the effect of addition of inhibitor proteins on the affinity between 
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RNase E and RhlB, or RNase E and enolase can be directed measured and compared. 
These in vitro experiments will also clarify whether the previous observed RraA/RraB 





















CHAPTER 5 CONCLUSIONS AND RECOMMENDATIONS 
This work sought to shed light on the roles and mechanisms of action of RraA and RraB, 
two small protein inhibitors of RNase E. The transcriptional regulation of rraA was 
investigated.  Microarray data had suggested that the rraA mRNA level increases upon 
entry into stationary phase.  We found that rraA is transcribed from its own protomer 
PrraA, located in the intergenic region between rraA and menA. The promoter PrraA was 
shown to be rpoS dependent (Zhao, Zhou, Kawarasaki, & Georgiou, 2006). 
The transcription of the rraB gene was shown to be more complicated. Like rraA, rraB is 
transcribed by its own promoter PrraB located in the intergenic region between rraB 
(yjgD) and argI. Although the expression of the rraB gene was to be repressed under 
tryptophan starvation conditions (Khodursky et al., 2000), we found no evidence that the 
promoter activity of PrraB is sensitive to the availability of tryptophan.  Similarly, 
arginine availability does not affect the PrraB promoter activity either, even though the 
gene encoding the Arg repressor protein ArgI overalps PrraB in E.coli and this genomic 
organization is conserved in several species of proteobacteria. To explore the 
physiological significance of rraB, transposon mutagenesis followed by screening for 
higher LacZ activity from a PrraB::lacZ transcriptional fusion was employed. A 
transposon mutant library was generated, and more than 30, 000 colonies were screened 
based on LacZ activity as monitored by blue-white screening.  A transposon insertion 
that occurred near the central region of the glmS gene resulted in elevated expression of 
lacZ from the PrraB promoter. This was further confirmed with complementary assays 
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examining the effect of Glucosamine-6-Phosphate, the end-product of the enzyme GlcN-
6-P synthase. The mechanism by which reduced activity of GlmS affects RraB 
expression awaits further investigation. 
In vitro RraA and RraB were demonstrated to exhibit a moderate inhibitory effect on 
RNase E hydrolysis of a 14mer FRET RNA substrate.  We showed that the RNase E 
1045 resulted in a higher Km compared to a fragment comprising of only the catalytic 
domain (1-498aa).  One possible explanation for this observation is that there is 
competition for RNA binding among the RNA binding motifs located within the catalytic 
core and the central region of RNase E. Degradation of long, structured RNA such as 
RNA1 and dsbC mRNA requires the coordination of activities between RNase E and 
RhlB. Because the binding sites of RraA and RraB overlap with the RhlB binding site on 
RNase E, it is reasonable to postulate that the inhibitory effect might result from 
displacement or interference with RhlB activity However, we also observed that the 
cleavage of the dsbC mRNA was inhibited much more strongly than that of RNA1 
indicating that the presence of RraA affects other factors in RNA turnover in addition to 
RhlB. Of note, our study of the RNA degradosome is the first reconstitution analysis of 
this RNA processing machinery by adding back the RNA degradosome component one 




We have demonstrated in this work how RraA and RraB inhibit RNA processing by the 
RNA degradosome. However, the effect of the inhibitor proteins on the degradosome 
composition had not been investigated. Size exclusive chromatography, co-immuno 
precipitation or sedimentation analysis can be employed to evaluate the molecular weight 
of degradosome in the presence of different molar ratios of RraA/RraB. An rraA- rraB- 
double mutatnt is viable and does not display significant growth defects indicating that 
E.coli may encode additional Rnase E inhibitors. One way to identify genes encoding 
such proteins would be to search for synthetic lethal alleles. A convenient synthetic 
lethality screen is now available (Bernhardt & de Boer, 2004). Briefly, a copy of wild 
type rraA gene is carried on an F plasmid, as well as a downstream reporter lacZ and the 
plasmid is transformed into a host devoid of rraA.  Formation of a colony with a blue 
center and white edges on LB agar plate is the result from the loss of F plasmid (which is 
unstable in a particular genetic background) during replication. However, when a gene X 
(unknown gene) which is required for supplementing rraA function is disrupted by 
mutagenesis of rraA- strain, the loss of F plasmid would be lethal under such 
circumstances thereby forming solid blue colonies that retain the F plasmid.  In this way, 
we expect discover more RNase E modulators, or additional physiological functions of 
RraA.  However it should be noted that a preliminary search for synthetic lethal alleles 
was not successful (data not shown).   
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RNA1 plays a significant role in control of ColE1 origin plasmid replication, and its 
degradation by RNase E is well established. In wild type E.coli strains, the half life of 
RNA1 is about 3 mins.  An engineered RNA1 which is less susceptible to RNase E 
degradation, yet functionally active, i.e. forms a complex with RNAII and inhibits 
plasmid replication could be useful in fine tuning the plasmid copy number at will. 
Putting such RNA under a controlled promoter could add another layer of plasmid copy 











APPENDIX: GLOBAL ANALYSIS OF E.COLI  RNA 
DEGRADOSOME FUNCTION  
Introduction 
Transcriptional regulation in bacteria has been under extensive study since the beginning 
of the molecular biology era. Much attention has been given on the post-transcription 
modification of mRNA during the past decade. These modifications include the binding 
of translational repressors/activators, formation of RNA secondary structures that inhibit 
turnove or ribosome binding, and the nucleolytic or phosphorylytic cleavage of 
mRNA.  These modifications can activate/inactivate mRNA in terms of its function as a 
translational template, or stabilize/degrade mRNA Pulse-labeling and hybridization 
techniques have been used to measure the chemical half life of mRNA (based on the 
assumption that adding rifampicin blocks transcription). Microarray analyses have been 
employed to measure mRNA steady-state levels as well as half life of transcripts at the 
genome scale. Overall, these methods gave us limited information on the functional half 
life of mRNA i.e. how long an mRNA remains intact and accessible for translation. The 
assessment of mRNA functional half life is far more difficult and has relied on either an 
immunochemical or enzymatic assays.  
A recently developed shotgun proteomic method, APEX (Absolute Protein Expression 
Index) can be used to evaluate the complete set of protein expression levels at the whole 
genome level (Lu, Vogel, Wang, Yao, & Marcotte, 2007). 
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Recent studies indicate that the assembled degradosome complex is necessary for normal 
mRNA degradation. Degradosome components functionally interact with each other 
during the decay of at least some RNAs in E. coli. There is an inverse relation between 
the mRNA decay rate and its cellular abundance. Previous work a showed that mRNAs 
encoded by genes with related functions commonly have similar half-lives (Bernstein, 
Khodursky, Lin, Lin-Chao, & Cohen, 2002). The DNA microarray study conducted by 
Bernstein et al. evaluated the steady-state level and decay of 4,289 E. coli mRNAs in 
strains carrying mutations in RNase E, PNPase, RhlB and enolase. The results indicated 
that certain mRNA decay involves the coordination from the degradosome components 
whereas other mRNA degradation is conducted or affected by individual components 
independently (Bernstein, Lin, Cohen, & Lin-Chao, 2004). 
It is important to distinguish the chemical and functional half life of mRNA. If an mRNA 
is chemically degraded, it is not functional for translation, however, if an mRNA cannot 
be translated (i.e. functionally inactive) it doesn′t necessarily mean that it has been 
chemically degraded.  To this end, we used APEX proteomic method to monitor the 




Materials and Methods 
APEX METHOD, SAMPLE PREPARATION AND DATA ANALYSIS 
 Cells are grown at 30 °C in M9 media supplied with 0.2% tryptone, 0.2% glycerol, 1mM 
MgSO4 and 0.0001% thiamine (For strains K10 and DF261, 40mM Succinate are added 
in the culture). Pellets are harvested at A600 of 0.6, resuspended in Lysis Buffer (25mM 
Tris HCl, 1mM EDTA pH7.5, before use, add 2.5mM DTT and 1x Roche Protease 
inhibitor) and lysed by French Press (20,000 psi, thrice). Soluble fractions after 
centrifugation (10,000g, 10min, at 4°C) are diluted into 4mg/ml. (Protein concentration 
determined by Nanodrop). Protein samples are denatured at 95 °C, 15min. After cool 
down to room temperature, trypsin solution (Sigma) was added at 1:50 (w/w). Digestions 
were carried out at 37 °C for 24hours. Sample after digestions were centrifuged through 
Micron YM-10 centrifuge device. The flow-through is subjected to APEX analysis 
according to Peng Lu et al. 
CORRELATION OF MRNA AND PROTEIN USING PROG.PL 
 In order to compare microarray RNA data and APEX protein data, a PERL script is 
developed to match genes in RNA.txt file and genes in Protein.txt file, calculate the 
product of their associated values (log base 10(RNA/Protein fold change)), and return 
this product and the original RNA/Protein value in the output file result.txt. The script of 
this program is as follows: 
 # this program is called in xxx.pl fileRNA.txt fileProtien.txt 
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my $numArgs = @ARGV; 
 
if($numArgs != 2){ 




open($fileRNA,$ARGV[0]) || die("fileRNA can not be opened.\n"); 
 
my $fileProtien; 






$tmp = <$fileRNA>;#just skip the first line 
my @inputArray = <$fileRNA>; #read RNA file 
my $length = @inputArray; #length of array 
for (my $count=0 ; $count<$length ; $count++){ 
 @tmp = split(/\t/, @inputArray[$count]); 
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 @geneName[$count] = @tmp[0]; 




$tmp = <$fileProtien>; 
my @inputArray2 = <$fileProtien>;#read protien file 




for($count=0 ; $count<$length ; $count++){ 
 @tmp = split(/\t/, @inputArray2[$count]); 
 @geneName2[$count] = @tmp[0]; 




#for each element in file RNA, find the corresponding record in file protien file according 
to gene name. If the record is found, then compare the product of RNA and protien value 







my @index = 0; 
 
$length = @geneName; 
$length2 = @geneName2; 
for(my $i=0 ; $i<$length ; $i++){ 
 for(my $j=0 ; $j<$length2 ; $j++){ 
  if(@geneName[$i] ne @geneName2[$j]){ 
   next; 
  } 
  #find it 
  @geneName3[$index] = @geneName[$i]; 
 
  my $z = @RNA[$i] * @protien[$j]; 
  @correlation[$index] = $z; 
 
  @RNA2[$index] = @RNA[$i]*1; 




  $index++; 




#write found records 
($index > 0) || die("No correspingding records found.\n"); 
 
my $fileResult; 
open($fileResult, ">result.txt") || die("Can not open output file"); 
print $fileResult ("gene\tcorrelation\tRNA\tprotien\n");#title 
 
$length = @geneName3; 
 
for($count=0 ; $count<$length ; $count++){ 







Results and Discussion  
PROTEINS IDENTIFIED IN APEX AND DATA VALIDATION.   
Strains in Table 1 carrying degradosome component deletions were cultured in minimal 
media to log phase. Cells were collected, lysed by French press. Soluble fractions are 
completely digested by trypsin to generate peptide samples for Mass spectrometry 
analysis. About 1000 to 1500 proteins could be identified from each sample. (Table 1) 
To evaluate the validity of the mass proteomic data we used two approaches: knowledge 
based validation and experimental validation.  
First we checked the APEX values for proteins whose encoding gene had been deleted.  
In the YHC012 strain carrying the Tn5::pnp mutation, the amount of Pnpase protein was 
less than 1/10 of that detected in the parental strain (APEX fold change value, log (base 
10)  is -1.19, with significance z-score -14.06).  Similar reductions in RhlB and Enolase 
protein abundance were (values) observed in the rhlB mutant and eno mutant 
respectively.  In the rne truncation mutation it is well known that the RNase E protein, is 
overproduced and this was also reflect in the abundance of the protein by APEX. 
Due to the limitation of available protein-specific antibodies, we tested several 
significantly increased or decreased proteins based on the availability of the antibody. 
GlmS protein shows an increase in YHC012 strain and decrease in SU02 strain compared 
to their wildtype N3433 strain. This was been confirmed by quantitative western blotting 
using polyclonal antibodies against GlmS. Similar experimental validation using anti-
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CspE antibody and anti-OmpA antibody were also consistent with APEX values (data not 
shown).   
Table A.1 Strains carrying mutations in the major degradosome components 
Strain Genotype Number of 
proteins identified 
 N3433 lacZ, relA, spot1, thi1 1540 
YHC012 N3433 except for Tn5::pnp 1008 
SU02 N3433 except for  ∆rhlB 1379 
SH3208 his ∆trpE5(λ) 1448 
BZ453 SH3208 except for rne truncation 1372 
K10 garB10, fhuA22, ompF627(T2
R), fadL701(T2
R), relA1, 
pit-10, spoT1, rrnB-2, mcrB1, creC510 
1248 
DF261 K10 except for eno-2 1322 
  
PROTEINS AFFECTED BY TWO OR MORE DEGADOSOME MUTANTS  
The abundance of several proteins was found to be affected in a similar manner in pnp 
and rhlB mutant strains. As a complex managing the decay of mRNA, one would expect 
the loss of coordination in mRNA decay will alter the protein levels accordingly.  To our 
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surprise there were very few proteins whose level was affected in the same manner in all 
degradosome mutants. This data is summarized in Table 3.   
Table A.2 Number of proteins which has significant abundance change in various 
degradosome component mutants (red: increase; green: decrease in mutants) 
in 2 mutants eno Pnp rhlB rne 
Eno  31 23 41 
Pnp 20  278 73 
rhlB 25 67  61 
Rne 73 14 23  
 
in 3 mutants increased Decreased 
eno pnp rhlB 17 8 
eno pnp rne 10 5 
rhlB rne eno 9 7 
rhlB rne pnp 45 8 
in all four mutants 7 3 
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CORRELATION BETWEEN MRNA AND PROTEIN LEVELS  
Bernstein et al. used microarrays to identify transcripts that are over or under represented 
in the four degradosome mutants discussed above. Only 286 transcripts showed similar 
changes in all four mutations (Bernstein, Lin, Cohen, & Lin-Chao, 2004).  They also 
measured mRNA half life in various strains and obtained mRNA half lives for about 
2000 transcripts in these mutant strains.  
We sought to determine whether there is a correlation between changes in mRNA 
abundance and protein abundance. We developed a perl program to compare the APEX 
protein data with the earlier RNA transcriptional profile data. In this program we 
compared the mRNA steady state level change with the protein level change by 
calculating the product of the respective fold-changes (log base 10 value). If the 
product>0, it means the RNA level and protein level are changing in a coordinated 
fashion (both increase/decrease) and vice versa. The cut-off of protein folds change data 
were 1.5x and 0.67x fold-change for increased or decreased abundances respectively. The 
results are summarized in Table 3.   
Table A.3. Comparisons of mRNA and Protein. 
strains correlationconsistentinconsistentTotal 
eno 0.446328 158 196 354 
pnp 0.567358 219 167 386 
rhlB 0.572539 221 137 386 




Several facts contribute to the existence of irrelevancy between the mRNA and protein.  
First microarray analysis measures the chemical half life, as stated above; transcripts that 
quickly adapted to a translational inactive structure can have a long chemical half-life and 
show high abundance chemically but have a short functional half life and cannot be 
translated. Second, the various mutants used in this study may affect rates of protein 
degradation.  
Further data analysis regarding to the details of the pathways to which this correlated (or 
not correlated) genes belongs will provide more information on the significance of RNA 
degrasome as a means of gene expression control. Moreover, incorporation of RNase E 
inhibitors RraA and RraB in a similar study will be very useful in elucidating the function 
of these protein inhibitors. Of note, the previous study done by our group has already 
established the transcriptional profile under conditions of over-expressing RraA/RraB 
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